Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  HIV Infection

  Free Subscription

Articles published in AIDS

Retrieve available abstracts of 557 articles:
HTML format

Single Articles

    May 2022
  1. SHEN Y, Shiau S, Yin MT, Arpadi SM, et al
    Cytokines in HIV infection: authors' reply.
    AIDS. 2022;36:908-909.

  2. MUNHOZ LGC, De Moraes-Pinto MI
    Cytokines in HIV infection: different methods of assessment require different interpretations.
    AIDS. 2022;36:907-908.

  3. CICHOWITZ C, Masoza T, Peck RN
    Air pollution and preclinical atherosclerotic cardiovascular disease in adolescents living with HIV: an opportunity for prevention.
    AIDS. 2022;36:901-902.

    Strategies to improve HIV care outcomes for people with HIV who are out of care: the need for well designed health systems.
    AIDS. 2022;36:899-900.

  5. NEL J, Gupta-Wright A
    Urine tuberculosis diagnostics in patients with advanced HIV.
    AIDS. 2022;36:897-898.

    April 2022
  6. TETENS MM, Gerstoft J, Kronborg G, Johansen IS, et al
    Risk of subarachnoid haemorrhages and aneurysms in Danish People Living With HIV, a nationwide cohort study.
    AIDS. 2022 Apr 27. pii: 00002030-990000000-00014.
    PubMed     Abstract available

  7. AUNG HL, Gates TM, Mao L, Brew BJ, et al
    Abnormal cognitive aging in people with HIV: Evidence from Data Integration between two countries' cohort studies.
    AIDS. 2022 Apr 27. pii: 00002030-990000000-00013.
    PubMed     Abstract available

  8. KAZEMIAN P, Ding DD, Scott JA, Feser MK, et al
    The cost-effectiveness of a resilience-based psychosocial intervention for HIV prevention among men who have sex with men in India.
    AIDS. 2022 Apr 26. pii: 00002030-990000000-00012.
    PubMed     Abstract available

  9. SAX PE, Andreatta K, Molina JM, Daar ES, et al
    High Efficacy of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in People with Suppressed HIV and Preexisting M184 V/I.
    AIDS. 2022 Apr 23. pii: 00002030-990000000-00011.
    PubMed     Abstract available

  10. WONG NS, Wong BCK, Chan JMC, Wong KH, et al
    Surrogate neutralisation responses following SARS-CoV-2 vaccination in people living with HIV - comparison between inactivated and mRNA vaccine.
    AIDS. 2022 Apr 23. pii: 00002030-990000000-00010.
    PubMed     Abstract available

  11. VOGT SL, Maloma L, Xian RR, Ambinder RF, et al
    Significance of lymph node fine needle aspiration for the diagnosis of HIV-associated lymphoma in a low-resource setting.
    AIDS. 2022 Apr 23. pii: 00002030-990000000-00009.
    PubMed     Abstract available

  12. WEINBERG A, Giganti MJ, Sirois PA, Montepiedra G, et al
    Coordination of inflammatory responses in children with perinatally-acquired HIV infection.
    AIDS. 2022 Apr 20. pii: 00002030-990000000-00008.
    PubMed     Abstract available

  13. LEVI LI, Sharma S, Schleiss MR, Furrer H, et al
    Cytomegalovirus viremia and risk of disease progression and death in HIV-positive patients starting antiretroviral therapy.
    AIDS. 2022 Apr 20. pii: 00002030-990000000-00007.
    PubMed     Abstract available

  14. PONTICIELLO M, Mwanga-Amumpaire J, Tushemereirwe P, Nuwagaba G, et al
    How informal healthcare providers improve uptake of HIV testing: qualitative results from a randomized controlled trial.
    AIDS. 2022 Apr 20. pii: 00002030-990000000-00006.
    PubMed     Abstract available

  15. MONTEJANO R, Marcelo C, Falces-Romero I, Del Valle LG, et al
    Efficacy of sotrovimab for persistent coronavirus disease-2019 in a severely immunocompromised person living with HIV.
    AIDS. 2022;36:751-753.

  16. GENER AR, Kottilil S
    Toward demystifying HIV as a risk factor for coronavirus disease 2019 complications.
    AIDS. 2022;36:749-750.

  17. BERNARDINO JI, Srinivasa S
    Proprotein convertase subtilisin/kexin type 9 inhibitors: a turning point in HIV-associated dyslipidemia?
    AIDS. 2022;36:745-747.

  18. OLALLA-SIERRA J, Martin-Escalante MD, Garcia-Alegria J, Rubio-Rivas M, et al
    Coronavirus disease 2019 hospitalization outcomes in persons with and without HIV in Spain.
    AIDS. 2022;36:683-690.
    PubMed     Abstract available

  19. FILIP I
    Getting to the heart of the matter: the need for tailored cardiovascular prevention strategies in patients with HIV.
    AIDS. 2022;36:N1-N3.

  20. JOSEPH J, Boeke CE, Makadzange EE, Sithole K, et al
    Near-point-of-care viral load testing during pregnancy and viremia at delivery.
    AIDS. 2022;36:711-719.
    PubMed     Abstract available

    March 2022
  21. MAZZITELLI M, Sasset L, Trunfio M, di Meco E, et al
    Use of self-prescribed medications and complementary medicines in a cohort of women with HIV.
    AIDS. 2022;36:617-619.

    HIV and SARS-CoV-2 biochemical interactions may not explain clinical outcomes among adults hospitalized with COVID-19 co-infected with HIV: authors' reply.
    AIDS. 2022;36:616-617.

  23. HUANG J, Liao L, Wang Y, Liu Q, et al
    Antagonism between hydrogen bonding and secondary chemical bonding to calcium in viruses.
    AIDS. 2022;36:615-616.

  24. LEPIK KJ, Wang L, Harris M, Mclinden T, et al
    Evolving patterns of antiretroviral drug interactions in people living with HIV in British Columbia, Canada.
    AIDS. 2022 Mar 11. pii: 00002030-990000000-00005.
    PubMed     Abstract available

  25. LEFEBVRE M, Secher S, Bouchez S, Vandamme YM, et al
    Measles seroprevalence in human immunodeficiency virus-infected adults born in the era of measles vaccination.
    AIDS. 2022 Mar 8. pii: 00002030-990000000-00002.
    PubMed     Abstract available

  26. LE HINGRAT Q, Collin G, Bachelard A, Ghosn J, et al
    Ibalizumab shows in vitro activity against group A and group B HIV-2 clinical isolates.
    AIDS. 2022 Mar 8. pii: 00002030-990000000-00001.
    PubMed     Abstract available

  27. RIAL-CRESTELO D, Otero B, Perez-Ayala A, Pinto A, et al
    Severe diarrhea by Cystoisospora belli in a well controlled HIV-infected patient.
    AIDS. 2022;36:485-486.

  28. SIM BZ, Smith LK, Yarwood T, Smith S, et al
    Successful treatment of HIV-associated progressive multifocal leukoencephalopathy with pembrolizumab.
    AIDS. 2022;36:483-485.

  29. XU X, Vesterbacka J, Aleman S, Nowak P, et al
    High seroconversion rate after vaccination with mRNA BNT162b2 vaccine against SARS-CoV-2 among people with HIV - but HIV viremia matters?
    AIDS. 2022;36:479-481.
    PubMed     Abstract available

    The persistent disparity in brain health among aging people with HIV.
    AIDS. 2022;36:475-477.

  31. POST JJ, Benfield T, Woolley I
    When pandemics collide: measuring the impact of coronavirus disease 2019 on people with HIV.
    AIDS. 2022;36:473-474.

  32. STIRRUP O, Tostevin A, Ragonnet-Cronin M, Volz E, et al
    Diagnosis delays in the UK according to pre or postmigration acquisition of HIV.
    AIDS. 2022;36:415-422.
    PubMed     Abstract available

  33. ROUT SS, Di Y, Dittmer U, Sutter K, et al
    Distinct effects of treatment with two different interferon-alpha subtypes on HIV-1-associated T-cell activation and dysfunction in humanized mice.
    AIDS. 2022;36:325-336.
    PubMed     Abstract available

    February 2022
  34. PIMENTEL VF, Pingarilho M, Sole G, Alves D, et al
    Differential patterns of post-migration HIV-1 infection acquisition among Portuguese immigrants of different geographical origin.
    AIDS. 2022 Feb 25. pii: 00002030-900000000-96205.
    PubMed     Abstract available

  35. NANCE RM, Delaney JAC, Floyd JS, Saag MS, et al
    Risk factors for atrial fibrillation in a multi-center US clinical cohort of people with HIV infection.
    AIDS. 2022 Feb 25. pii: 00002030-900000000-96204.
    PubMed     Abstract available

  36. DAUBY N, Gobert C, Benslimane A, Nagant C, et al
    Durability of tetanus seroprotection in people living with HIV.
    AIDS. 2022 Feb 24. pii: 00002030-900000000-96211.
    PubMed     Abstract available

  37. DASGUPTA S, Crim SM, Dawson L, Kates J, et al
    Unmet needs for HIV ancillary care services by health care coverage and Ryan White HIV/AIDS program assistance.
    AIDS. 2022 Feb 24. pii: 00002030-900000000-96210.
    PubMed     Abstract available

  38. YAP SH, Lee CS, Furusho A, Ishii C, et al
    Plasma D-amino acids are associated with markers of immune activation and organ dysfunction in people living with HIV.
    AIDS. 2022 Feb 24. pii: 00002030-900000000-96209.
    PubMed     Abstract available

  39. TORIAN LV, Forgione L, Wertheim JO
    Using molecular epidemiology to trace the history of the injection-related HIV epidemic in New York City, 1985-2019.
    AIDS. 2022 Feb 24. pii: 00002030-900000000-96208.
    PubMed     Abstract available

  40. TUMKOSIT M, Han WM, Tankittiwat K, Chattranukulchai P, et al
    Higher epicardial fat in older adults living with HIV with viral suppression and relationship with liver steatosis, coronary calcium and cardiometabolic risks.
    AIDS. 2022 Feb 24. pii: 00002030-900000000-96207.
    PubMed     Abstract available

  41. ZANG X, Goedel WC, Bessey SE, Lurie MN, et al
    The impact of syringe services program closure on the risk of rebound HIV outbreaks among people who inject drugs: A modeling study.
    AIDS. 2022 Feb 24. pii: 00002030-900000000-96206.
    PubMed     Abstract available

  42. HAMIDOUCHE M, Ante-Testard PA, Baggaley R, Temime L, et al
    Monitoring socioeconomic inequalities across HIV knowledge, attitudes, behaviours and prevention in 18 sub-Saharan African countries.
    AIDS. 2022 Feb 21. pii: 00002030-900000000-96212.
    PubMed     Abstract available

  43. DUGUE R, Schnall R, Liu M, Brickman AM, et al
    Uncontrolled HIV and inflammation is associated with intracranial saccular aneurysm presence: a preliminary study.
    AIDS. 2022 Feb 18. pii: 00002030-900000000-96214.
    PubMed     Abstract available

  44. FLETCHER CV, Kroon E, Schacker T, Pinyakorn S, et al
    Persistent HIV transcription and Variable ARV penetration in lymph nodes during plasma viral suppression.
    AIDS. 2022 Feb 18. pii: 00002030-900000000-96213.
    PubMed     Abstract available

  45. ALI MS, Wit MDE, Chabata ST, Magutshwa S, et al
    Estimation of HIV incidence from analysis of HIV prevalence patterns by age and years since starting sex work among female sex workers in Zimbabwe.
    AIDS. 2022 Feb 16. pii: 00002030-900000000-96216.
    PubMed     Abstract available

  46. HAWKINS C, Kang M, Bhattacharya D, Cloherty G, et al
    Hepatitis B surface antigen and Hepatitis B RNA changes in HIV/HBV Co-infected participants receiving HBV-active antiretroviral therapy for 144 weeks.
    AIDS. 2022 Feb 14. pii: 00002030-900000000-96218.
    PubMed     Abstract available

  47. WANJALLA CN, Temu TM, Mashayekhi M, Warren CM, et al
    IL-17A is associated with flow-mediated dilation and IL-4 with carotid plaque in persons with HIV.
    AIDS. 2022 Feb 14. pii: 00002030-900000000-96217.
    PubMed     Abstract available

  48. DAVIES C, Johnson L, Sawry S, Chimbetete C, et al
    Effect of antiretroviral therapy care interruptions on mortality in children living with HIV: cohort study from Southern Africa.
    AIDS. 2022 Feb 11. pii: 00002030-900000000-96220.
    PubMed     Abstract available

  49. VINK FJ, Steenbergen RDM, Kremer WW, Lissenberg-Witte BI, et al
    Post-treatment monitoring by ASCL1/LHX8 methylation analysis in women with HIV treated for cervical intraepithelial neoplasia grade 2/3.
    AIDS. 2022 Feb 11. pii: 00002030-900000000-96219.
    PubMed     Abstract available

  50. ZEGGAGH J, Bauer R, Delaugerre C, Carette D, et al
    Incidence and risk factors for recurrent sexually transmitted infections among men who have sex with men on HIV pre-exposure prophylaxis.
    AIDS. 2022 Feb 9. pii: 00002030-900000000-96224.
    PubMed     Abstract available

  51. GARCIA-OTERO L, Walles J, Balcha TT, Merga G, et al
    Cardiovascular effects of intrauterine exposure to maternal HIV and antiretroviral therapy in Ethiopian infants followed from fetal life.
    AIDS. 2022 Feb 9. pii: 00002030-900000000-96223.
    PubMed     Abstract available

  52. HUGUELEY B, Mcclung RP, Saduvala N, Oster AM, et al
    Baseline HIV drug resistance testing: 12 U.S. jurisdictions, 2014-2019.
    AIDS. 2022 Feb 9. pii: 00002030-900000000-96222.
    PubMed     Abstract available

  53. MANGURIAN C, Dahiya P, Goldman ML, Corbeil T, et al
    Underdetection of pre-existing HIV/AIDS during psychiatric hospitalizations.
    AIDS. 2022 Feb 9. pii: 00002030-900000000-96221.
    PubMed     Abstract available

  54. TOE S, Nagy M, Albar Z, Yu J, et al
    Ambient air pollution is associated with vascular disease in ugandan HIV positive adolescents.
    AIDS. 2022 Feb 8. pii: 00002030-900000000-96226.
    PubMed     Abstract available

  55. JENNINGS L, Robbins RN, Nguyen N, Ferraris C, et al
    Tenofovir diphosphate in dried blood spots predicts future viremia in persons with HIV taking antiretroviral therapy in south africa.
    AIDS. 2022 Feb 8. pii: 00002030-900000000-96225.
    PubMed     Abstract available

  56. DURIER C, Mercier-Delarue S, Verdiere NC, Meiffredy V, et al
    A 5-year neutralizing immune response to yellow fever vaccine in HIV-infected and HIV-uninfected adults.
    AIDS. 2022;36:319-321.

  57. VAN EMPEL E, De Vlieg RA, Harling G, Marcus ME, et al
    Reaching for the 'first 95': a cross-country analysis of HIV self-testing in nine countries in sub-Saharan Africa.
    AIDS. 2022;36:297-304.
    PubMed     Abstract available

  58. LU H, Cole SR, Westreich D, Hudgens MG, et al
    Virologic outcomes among adults with HIV using integrase inhibitor-based antiretroviral therapy.
    AIDS. 2022;36:277-286.
    PubMed     Abstract available

  59. KUNIHOLM MH, Vasquez E, Appleton AA, Kingsley L, et al
    Cardiovascular risk score associations with frailty in men and women with or at risk for HIV.
    AIDS. 2022;36:237-347.
    PubMed     Abstract available

  60. DEL AMO J, Polo R, Moreno S, Jarrin I, et al
    SARS-CoV-2 infection and coronavirus disease 2019 severity in persons with HIV on antiretroviral treatment.
    AIDS. 2022;36:161-168.
    PubMed     Abstract available

  61. HERMANS LE, Hofstra LM, Schuurman R, Ter Heine R, et al
    HIV-1 pretreatment drug resistance negatively impacts outcomes of first-line antiretroviral treatment - week 96 results from the ITREMA trial.
    AIDS. 2022 Feb 1. pii: 00002030-900000000-96229.
    PubMed     Abstract available

  62. SHAVER ZM, Anderson M, Bhebhe L, Baruti K, et al
    Decreased HBV vaccine response among HIV positive infants compared to HIV negative infants in Botswana.
    AIDS. 2022 Feb 1. pii: 00002030-900000000-96228.
    PubMed     Abstract available

  63. LACHATRE M, Pasquet A, Ajana F, Soudan B, et al
    Hypogonadism: a neglected comorbidity in young and middle-aged HIV-positive men on effective cART.
    AIDS. 2022 Feb 1. pii: 00002030-900000000-96227.
    PubMed     Abstract available

  64. MURDOCH IG, Jacobs TG, Nieuwenhuize RM, van Rossum-Schornagel QC, et al
    Ritonavir-boosted antiretroviral therapy with paclitaxel: will it lead to boosted toxicity?
    AIDS. 2022;36:322-323.

  65. GUANIRA JV, Fichtenbaum CJ
    Is it time to retire efavirenz as a first-line option worldwide?
    AIDS. 2022;36:317-318.

  66. JABS DA, Van Natta ML, Schneider MF, Pak JW, et al
    Association of elevated plasma inflammatory biomarker levels with age-related macular degeneration but not cataract in persons with AIDS.
    AIDS. 2022;36:177-184.
    PubMed     Abstract available

    January 2022
  67. WAKE RM, Govender NP, Omar SV, Ismail F, et al
    Rapid urine-based screening tests increase the yield of same-day tuberculosis diagnoses among patients living with advanced HIV disease.
    AIDS. 2022 Jan 24. pii: 00002030-900000000-96230.
    PubMed     Abstract available

  68. LI B, Zhang L, Liu Y, Xiao J, et al
    A novel prediction model to evaluate the probability of CD4/CD8 ratio restoration in HIV-infected individuals.
    AIDS. 2022 Jan 14. pii: 00002030-900000000-96239.
    PubMed     Abstract available

  69. HIGA DH, Crepaz N, Mullins MM, Adegbite-Johnson A, et al
    Strategies to improve HIV care outcomes for people with HIV who are out of care: a meta-analysis.
    AIDS. 2022 Jan 12. pii: 00002030-900000000-96232.
    PubMed     Abstract available

  70. BOCCARA F, Caramelli B, Calmy A, Kumar P, et al
    Long-term effects of evolocumab in participants with HIV and dyslipidemia: results from the open-label extension period.
    AIDS. 2022 Jan 12. pii: 00002030-900000000-96231.
    PubMed     Abstract available

  71. JAKABEK D, Rae CD, Brew BJ, Cysique LA, et al
    Brain aging and cardiovascular factors in HIV: A longitudinal volume and shape MRI study.
    AIDS. 2022 Jan 10. pii: 00002030-900000000-96242.
    PubMed     Abstract available

  72. HASSOLD N, Brichler S, Ouedraogo E, Leclerc D, et al
    Impaired antibody response to COVID-19 vaccination in advanced HIV infection.
    AIDS. 2022 Jan 10. pii: 00002030-900000000-96241.
    PubMed     Abstract available

  73. DE LAZZARI E, Martinez-Mimbrero A, Chivite I, Gonzalez-Cordon A, et al
    Impact of COVID-19 epidemics on prevention and care for HIV and other sexually transmitted infections.
    AIDS. 2022 Jan 10. pii: 00002030-900000000-96240.
    PubMed     Abstract available

  74. CARRASCO I, Olveira A, Lancharro A, Escosa L, et al
    Prevalence of non-alcoholic fatty liver disease using non-invasive techniques among children, adolescents, and youths living with HIV.
    AIDS. 2022 Jan 10. pii: 00002030-900000000-96238.
    PubMed     Abstract available

  75. NOVAK RM, Armon C, Battalora L, Buchacz K, et al
    Aging, trends in CD4/CD8 ratio and clinical outcomes with persistent HIV suppression in the HIV outpatient study (HOPS).
    AIDS. 2022 Jan 10. pii: 00002030-900000000-96237.
    PubMed     Abstract available

  76. CLARE M, Yang J, Lake JE, Abraham AG, et al
    Diabetes mellitus is associated with declines in physical function among men with and without HIV.
    AIDS. 2022 Jan 6. pii: 00002030-900000000-96247.
    PubMed     Abstract available

  77. ALEDO MG, Canizares A, Vazquez-Rodriguez P, Castro A, et al
    Safety and immunogenicity of SARS-CoV-2 mRNA-1273 and BNT162b2 vaccines in people living with HIV.
    AIDS. 2022 Jan 6. pii: 00002030-900000000-96246.
    PubMed     Abstract available

  78. ISFORDINK CJ, Smit C, Boyd A, de Regt MJA, et al
    Low HCV-viremia prevalence yet continued barriers to direct-acting antiviral treatment in people living with HIV in the Netherlands.
    AIDS. 2022 Jan 6. pii: 00002030-900000000-96245.
    PubMed     Abstract available

  79. CAMPBELL LM, Sun-Suslow N, Heaton A, Heaton RK, et al
    Fatigue is associated with worse cognitive and everyday functioning in older persons with HIV.
    AIDS. 2022 Jan 6. pii: 00002030-900000000-96244.
    PubMed     Abstract available

  80. JAROLIMOVA J, Platt LR, Curtis MR, Philpotts LL, et al
    Curable sexually transmitted infections among women with HIV in sub-Saharan Africa: systematic review and meta-analysis.
    AIDS. 2022 Jan 6. pii: 00002030-900000000-96243.
    PubMed     Abstract available

  81. ANDERSON AM, Bhondoekhan F, Curanovic D, Connelly MA, et al
    GlycA is associated with neuropsychological impairment in men with HIV.
    AIDS. 2022;36:156-159.

  82. ODENDAAL LN, Smit DP
    A triple case series of uveitis caused by HIV, syphilis and tuberculosis coinfection.
    AIDS. 2022;36:155-156.

  83. CALZA L, Borderi M, Colangeli V, Miani T, et al
    Weight gain in treatment-naive HIV-1 infected patients starting abacavir/lamivudine/dolutegravir or tenofovir alafenamide/emtricitabine/bictegravir.
    AIDS. 2022;36:153-155.

  84. ZHU J, Wu X
    Save young lives by determining causes of children death stratified by HIV status in resource-constrained countries.
    AIDS. 2022;36:149-151.

  85. GENER AR
    Anticipating HIV drug resistance with appropriate sequencing methods.
    AIDS. 2022;36:147-148.

  86. YANAVICH C, Perazzo H, Li F, Tobin N, et al
    A pilot study of microbial signatures of liver disease in those with HIV mono-infection in Rio de Janeiro, Brazil.
    AIDS. 2022;36:49-58.
    PubMed     Abstract available

  87. AUGUSTE PE, Mistry H, McCarthy ND, Sutcliffe PA, et al
    Cost-effectiveness of testing for latent tuberculosis infection in people with HIV.
    AIDS. 2022;36:1-9.
    PubMed     Abstract available

    December 2021
  88. KNIGHTS SM, Lazarte SM, Kainthla R, Chiao EY, et al
    Mortality disparities among patients with HIV-associated kaposi's sarcoma in the southern united states.
    AIDS. 2021 Dec 22. pii: 00002030-900000000-96248.
    PubMed     Abstract available

  89. MCNEIL CJ, Lee JS, Cole SR, Patel SA, et al
    Anal cancer incidence in MSM with HIV: are black men at higher risk?
    AIDS. 2021 Dec 17. pii: 00002030-900000000-96252.
    PubMed     Abstract available

  90. DRAK D, Shamu T, Heron JE, Chimbetete C, et al
    Renal function and associated mortality risk in adults commencing HIV antiretroviral therapy in Zimbabwe.
    AIDS. 2021 Dec 17. pii: 00002030-900000000-96251.
    PubMed     Abstract available

  91. CHAUSSADE H, Le-Marec F, Coureau G, Leleux O, et al
    Incidence of lung and HPV-associated malignancies in HIV-infected patients.
    AIDS. 2021 Dec 17. pii: 00002030-900000000-96250.
    PubMed     Abstract available

  92. KINGWARA L, Inzaule SC, Momanyi L, Jordan MR, et al
    Impact of nucleos(t)ide reverse transcriptase inhibitor resistance on dolutegravir and protease-inhibitor based regimens in children and adolescents in Kenya.
    AIDS. 2021 Dec 17. pii: 00002030-900000000-96249.
    PubMed     Abstract available

  93. SHAH S, Pilkington V, Hill A
    Is tenofovir disoproxil fumarate associated with weight loss?
    AIDS. 2021;35.
    PubMed     Abstract available

  94. VENTER WDF, Sokhela S, Calmy A, Mkhondwane L, et al
    Weight gain stopping/switch rules for antiretroviral clinical trials.
    AIDS. 2021;35.
    PubMed     Abstract available

  95. JAMIESON L, Serenata C, Makhubele L, Sokhela S, et al
    Cost and cost-effectiveness of dolutegravir-based antiretroviral regimens: an economic evaluation of a clinical trial.
    AIDS. 2021;35.
    PubMed     Abstract available

  96. HARRIS EL, Blumer K, Perez Casas C, Ferris D, et al
    Accelerating access and scale-up of optimized antiretroviral therapy in low-income and middle-income countries: results of a coordinated end-to-end approach.
    AIDS. 2021;35.
    PubMed     Abstract available

  97. PAPOT E, Kaplan R, Vitoria M, Polizzotto MN, et al
    Optimizing switching strategies to simplify antiretroviral therapy: the future of second-line from a public health perspective.
    AIDS. 2021;35.

  98. SINXADI PZ, Khoo SH, Boffito M
    Pharmacokinetic interactions of modern antiretroviral therapy.
    AIDS. 2021;35.
    PubMed     Abstract available

  99. CHANDIWANA NC, Serenata CM, Owen A, Rannard S, et al
    Impact of long-acting therapies on the global HIV epidemic.
    AIDS. 2021;35.
    PubMed     Abstract available

  100. MCCLUSKEY SM, Pepperrell T, Hill A, Venter WDF, et al
    Adherence, resistance, and viral suppression on dolutegravir in sub-Saharan Africa: implications for the TLD era.
    AIDS. 2021;35.
    PubMed     Abstract available

  101. VENTER WDF, Serenata C, Vitoria M, Mkhondwane L, et al
    What we have learned from antiretroviral treatment optimization efforts over the last 5 years?
    AIDS. 2021;35.
    PubMed     Abstract available

  102. JANUS SE, Durieux JC, Hajjari J, Carneiro H, et al
    Inflammation mediated Vitamin K and Vitamin D effects on vascular calcifications in people with HIV on active antiretroviral therapy.
    AIDS. 2021 Dec 13. pii: 00002030-900000000-96253.
    PubMed     Abstract available

  103. LINTHWAITE B, Kronfli N, Marbaniang I, Ruppenthal L, et al
    Increased reengagement of out-of-care HIV patients using lost & found, a clinic-based intervention.
    AIDS. 2021 Dec 13. pii: 00002030-900000000-96254.
    PubMed     Abstract available

  104. RAWLINGS SA, Torres F, Wells A, Lisco A, et al
    Effect of HIV suppression on the cytokine network in blood and seminal plasma: A longitudinal study.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96262.
    PubMed     Abstract available

  105. MONTEBATSI M, Lavoie MC, Blanco N, Marima R, et al
    Improving same-day ART in botswana: effects of a multifaceted national intervention.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96260.
    PubMed     Abstract available

  106. DALLA-POZZA P, Hentzien M, Allavena C, Maindreville AD, et al
    Progressive multifocal leukoencephalopathy in patients with immuno-virological control and at least 6 months of combination antiretroviral therapy.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96259.
    PubMed     Abstract available

  107. CARO-VEGAS C, Ramirez C, Landis J, Adimora AA, et al
    Molecular profiling of breast and lung cancer in women with HIV reveals high tumor mutational burden.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96258.
    PubMed     Abstract available

  108. SCHNEIDER JA, Hayford C, Hotton A, Tabidze I, et al
    Do partner services linked to molecular clusters yield people with viremia or new HIV? results from a historical cohort study.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96257.
    PubMed     Abstract available

  109. GIROMETTI N, McCormack S, Tittle V, McOwan A, et al
    Rising rates of recent PrEP exposure among MSM newly diagnosed with HIV: antiviral resistance patterns and treatment outcomes.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96256.
    PubMed     Abstract available

  110. BEER L, Tie Y, Dasgupta S, McManus T, et al
    The COVID-19 pandemic and unemployment, 1 subsistence needs and mental health among adults with HIV in the United States.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96255.
    PubMed     Abstract available

  111. LIANG HJ, Ernst T, Cunningham E, Chang L, et al
    Contributions of chronic tobacco smoking to HIV-associated brain atrophy and cognitive deficits.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96265.
    PubMed     Abstract available

  112. YU W, Jacobson DL, Williams PL, Patel K, et al
    Growth patterns of uninfected children born to women living with perinatally- versus non-perinatally-acquired HIV.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96264.
    PubMed     Abstract available

  113. BAILIN SS, Kundu S, Wellons M, Freiberg MS, et al
    Circulating CD4+ TEMRA and CD4+ CD28- T cells and incident diabetes among persons with and without HIV.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96263.
    PubMed     Abstract available

  114. NIKANJAM M, Tran L, Chadwick EG, Bwakura-Dangarembizi M, et al
    Impact of CYP2B6 genotype, TB therapy and formulation on efavirenz pharmacokinetics in infants and children under 40 months of age.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96261.
    PubMed     Abstract available

  115. LEE DH, Shin JE, Kim CH
    Sudden sensorineural hearing loss with vertigo as an initial presenting symptom of HIV/AIDS patient.
    AIDS. 2021;35:2553-2555.

  116. CATTANEO D, Fusi M, Micheli V, Resnati C, et al
    Tenofovir plasma trough concentrations in people with HIV treated with doravirine versus other antiretroviral regimens.
    AIDS. 2021;35:2551-2553.

  117. SARKAR S, Bhondoekhan F, Haberlen S, Palella FJ Jr, et al
    The association of adipose tissue area with subclinical coronary atherosclerosis progression in men with and without HIV.
    AIDS. 2021;35:2549-2551.

  118. SPINELLI MA, Brown LB, Glidden DV, Hunter K, et al
    SARS-CoV-2 incidence, testing rates, and severe COVID-19 outcomes among people with and without HIV.
    AIDS. 2021;35:2545-2547.
    PubMed     Abstract available

  119. MARAGH-BASS AC, Parker S, Thompson G, Erlandson KM, et al
    'Ending the HIV epidemic': where are African American women in the plan?
    AIDS. 2021;35:2541-2544.

  120. SLACK C, Soudeyns H
    Key milestones and participant engagement strategies in research with HIV-affected adolescents and young adults from low-to-middle income countries.
    AIDS. 2021;35:2539-2540.

  121. TUCKER JD, Iwelunmor J, Abrams E, Donenberg G, et al
    Accelerating adolescent HIV research in low-income and middle-income countries: evidence from a research consortium.
    AIDS. 2021;35:2503-2511.
    PubMed     Abstract available

  122. RICHART V, Fernandez I, de Lazzari E, Berrocal L, et al
    High rate of long-term clinical events after antiretroviral therapy resumption in HIV-positive patients exposed to antiretroviral therapy interruption.
    AIDS. 2021;35:2463-2468.
    PubMed     Abstract available

  123. BOSWELL MT, Yindom LM, Hameiri-Bowen D, McHugh G, et al
    TRIM22 genotype is not associated with markers of disease progression in children with HIV-1 infection.
    AIDS. 2021;35:2445-2450.
    PubMed     Abstract available

  124. LIU D, Liu J, Xu T, Qiao H, et al
    Longitudinal trajectories of brain volume in combined antiretroviral therapy treated and untreated simian immunodeficiency virus-infected rhesus macaques.
    AIDS. 2021;35:2433-2443.
    PubMed     Abstract available

    November 2021
  125. LAM JO, Lee C, Gilsanz P, Hou CE, et al
    Comparison of dementia incidence and prevalence between individuals with and without HIV infection in primary care from 2000 to 2016.
    AIDS. 2021 Nov 24. pii: 00002030-900000000-96266.
    PubMed     Abstract available

  126. Statin exposure and risk of cancer in people with and without HIV infection: Erratum.
    AIDS. 2021;35:2411.

  127. PRESSIAT C, Toni TD, Treluyer JM, Yonaba C, et al
    High nevirapine levels in breast milk and consequences in HIV-infected child when initiated on antiretroviral therapy.
    AIDS. 2021;35:2409-2410.

  128. WANG P, McGovern M, Togo Y
    Geographic diversity in authorship of HIV randomized control trial publications.
    AIDS. 2021;35:2407-2409.

  129. BUKKEMS VE, Hidalgo-Tenorio C, Garcia C, van Hulzen AGW, et al
    First pharmacokinetic data of bictegravir in pregnant women living with HIV.
    AIDS. 2021;35:2405-2406.

  130. SNYMAN J, Sanders EJ, Ndung'u T
    COVID-19 in Africa: preexisting immunity and HIV.
    AIDS. 2021;35:2391-2393.

  131. DEAN LT, Chang HY, Goedel WC, Chan PA, et al
    Novel population-level proxy measures for suboptimal HIV preexposure prophylaxis initiation and persistence in the USA.
    AIDS. 2021;35:2375-2381.
    PubMed     Abstract available

  132. CARLANDER C, Lagheden C, Eklund C, Nordqvist Kleppe S, et al
    Nonvaccine human papillomavirus genotype common in women with HIV failing cervical precancer treatment.
    AIDS. 2021;35:2367-2374.
    PubMed     Abstract available

  133. LUCAS GM, Winslow DL
    New onset kidney impairment in a large pre-exposure prophylaxis demonstration project in New South Wales, Australia.
    AIDS. 2021;35:2395-2397.

  134. VANHAMEL J, Laga M
    Measuring progress in the roll-out of pre-exposure prophylaxis: from counting what we know, to knowing what to count.
    AIDS. 2021;35:2389-2390.

  135. TOULOUMI G, Thomadakis C, Pantazis N, Papastamopoulos V, et al
    HIV continuum of care: bridging cross-sectional and longitudinal analyses.
    AIDS. 2021 Nov 11. pii: 00002030-900000000-96268.
    PubMed     Abstract available

  136. DURSTENFELD MS, Sun K, Ma Y, Rodriguez F, et al
    Association of human immunodeficiency virus infection with outcomes among adults hospitalized with COVID-19.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96275.
    PubMed     Abstract available

  137. JEUDY J, Patel P, George N, Burrowes S, et al
    Assessment of coronary inflammation in antiretroviral treated people living with HIV infection and active HIV/HCV co-infection.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96274.
    PubMed     Abstract available

  138. CACHAY ER, Hasteh F, Mathews WC
    Using computer-assisted content analysis to advance anal dysplasia natural history research: a validation study.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96273.
    PubMed     Abstract available

  139. BIRABAHARAN M, Strunk A, Kaelber DC, Smith DM, et al
    Sex differences in type 2 diabetes mellitus prevalence among persons with HIV: a cross-sectional analysis.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96272.
    PubMed     Abstract available

  140. MOHAPI L, Pinedo Y, Osiyemi O, Supparatpinyo K, et al
    Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV: a randomized phase 3 study.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96271.
    PubMed     Abstract available

  141. NEARY J, Langat A, Singa B, Kinuthia J, et al
    Higher prevalence of stunting and poor growth outcomes in HIV-exposed uninfected than HIV-unexposed infants in Kenya.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96270.
    PubMed     Abstract available

  142. ALTHOFF KN, Stewart CN, Humes E, Zhang J, et al
    The shifting age distribution of people with HIV using antiretroviral therapy in the United States, 2020 to 2030.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96269.
    PubMed     Abstract available

  143. FOWLER MG, Aizire J, Sikorskii A, Atuhaire P, et al
    Growth deficits in antiretroviral and HIV exposed uninfected versus unexposed children in Malawi and Uganda persist through 60 months-of-age.
    AIDS. 2021 Nov 3. pii: 00002030-900000000-96277.
    PubMed     Abstract available

  144. MUNOZ-MORENO JA, Carrillo-Molina S, Martinez-Zalacain I, Miranda C, et al
    Preserved central nervous system functioning after use of romidepsin as a latency-reversing agent in an HIV cure strategy.
    AIDS. 2021 Nov 3. pii: 00002030-900000000-96276.
    PubMed     Abstract available

  145. YIN W, Panakadan S, Shwe YY, Peters K, et al
    Enhance harm reduction programmes in responding to the changing trend of drug use and HIV transmission in Asia and the pacific.
    AIDS. 2021;35:2229-2232.

  146. MOSES AK, Ghazi T, Naidoo DB, Chuturgoon A, et al
    DNA methylation of MEKKK1: a strategy to reactivate the NF-kappaB pathway and reverse HIV latency.
    AIDS. 2021;35:2221-2224.

  147. FORD N, Crawford KW, Ameyan W
    Rapidly starting antiretroviral therapy to improve outcomes among disadvantaged groups.
    AIDS. 2021;35:2217-2219.

  148. NICHOLS BE, Rosen S
    Economic evaluations of differentiated service delivery should include savings and ancillary benefits, not only health system costs: authors' reply.
    AIDS. 2021;35:2235-2236.

  149. CLAASSEN CW, Lindsay B, Riedel DJ, Kafunda I, et al
    Economic evaluations of differentiated service delivery should include savings and ancillary benefits, not only health system costs.
    AIDS. 2021;35:2234-2235.

  150. HEIL EL, Pandit NS, Taylor GH
    Probable hepatotoxicity from two second-generation integrase strand transfer inhibitors.
    AIDS. 2021;35:2232-2233.

  151. GENER AR
    Editorial commentary on 'the other side of screening: predictors of treatment and follow-up for anal precancers in a large health system'.
    AIDS. 2021;35:2215-2216.

  152. CACHAY ER, Hadigan C, Mathews WC
    Clinical guidelines for screening of liver cirrhosis complications remain, and clinical judgement must prevail.
    AIDS. 2021;35:2211-2213.

  153. SILVEIRA ELV, Hong JJ, Amancha PK, Rogers KA, et al
    Viremia controls Env-specific antibody-secreting cell responses in simian immunodeficiency virus infected macaques pre and post-antiretroviral therapy.
    AIDS. 2021;35:2085-2094.
    PubMed     Abstract available

    October 2021
  154. MALMSTROM S, Wagner P, Yilmaz A, Svedhem V, et al
    Failure to restore CD4 count associated with infection-related and non-infection-related cancer.
    AIDS. 2021 Oct 27. pii: 00002030-900000000-96281.
    PubMed     Abstract available

  155. EL-NAHAL WG, Shen NM, Keruly JC, Jones JL, et al
    Telemedicine and visit completion among people with HIV during the COVID-19 pandemic compared to pre-pandemic.
    AIDS. 2021 Oct 27. pii: 00002030-900000000-96280.
    PubMed     Abstract available

  156. BECASEN JS, Morris JD, Denard CL, Mullins MM, et al
    HIV care outcomes among transgender persons with HIV infection in the united states: a systematic review and meta-analysis, 2006-2021.
    AIDS. 2021 Oct 25. pii: 00002030-900000000-96286.
    PubMed     Abstract available

  157. FURSA O, Mocroft A, Lazarus JV, Amele S, et al
    The hepatitis C cascade of care in HIV/HCV-coinfected individuals in Europe- regional and intra-regional differences.
    AIDS. 2021 Oct 25. pii: 00002030-900000000-96284.
    PubMed     Abstract available

  158. QUINN JR, Goyal A, Ribeiro RM, Massaccesi G, et al
    Antiretroviral therapy for HIV and intrahepatic hepatitis C virus replication.
    AIDS. 2021 Oct 25. pii: 00002030-900000000-96283.
    PubMed     Abstract available

  159. CEDARBAUM ER, Ma Y, Adimora AA, Bamman M, et al
    Peripheral artery disease and physical function in women with and without HIV.
    AIDS. 2021 Oct 21. pii: 00002030-900000000-96285.
    PubMed     Abstract available

  160. RAMOS-RINCON JM, Menchi-Elanzi M, Pinargote-Celorio H, Mayoral A, et al
    Trends in hospitalizations and deaths in HIV-Infected patients in Spain over two decades.
    AIDS. 2021 Oct 20. pii: 00002030-900000000-96291.
    PubMed     Abstract available

  161. MILLS A, Richmond GJ, Newman C, Osiyemi O, et al
    Long-acting cabotegravir and rilpivirine for maintenance of HIV-1 suppression: pOLAR month 12 results.
    AIDS. 2021 Oct 13. pii: 00002030-900000000-96294.
    PubMed     Abstract available

  162. SIDDIQUI J, Samuel SK, Hayward B, Wirka KA, et al
    HIV-associated wasting prevalence in the era of modern antiretroviral therapy: a claims database study (2012-2018).
    AIDS. 2021 Oct 12. pii: 00002030-900000000-96296.
    PubMed     Abstract available

  163. EASTMENT MC, Wanje G, Richardson BA, Mwaringa E, et al
    Results of a cluster randomized trial testing the systems analysis and improvement approach to increase HIV testing in family planning clinics in Mombasa, Kenya.
    AIDS. 2021 Oct 8. pii: 00002030-900000000-96295.
    PubMed     Abstract available

  164. OLUNIYI PE, Ajogbasile FV, Zhou S, Fred-Akintunwa I, et al
    HIV-1 drug resistance and genetic diversity in a cohort of people living with HIV-1 in Nigeria.
    AIDS. 2021 Oct 7. pii: 00002030-900000000-96299.
    PubMed     Abstract available

  165. RONALD R, Gartland M, Li Z, Zhou N, et al
    Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maraviroc.
    AIDS. 2021 Oct 7. pii: 00002030-900000000-96298.
    PubMed     Abstract available

  166. YAN H, Peters H, Thorne C
    Neonatal deaths among infants born to women living with HIV in the UK and Ireland 1998-2017.
    AIDS. 2021 Oct 7. pii: 00002030-900000000-96297.
    PubMed     Abstract available

  167. BEZEMER D, Blenkinsop A, Hall M, van Sighem A, et al
    In-country acquisition of HIV-1 non-B infection within the Netherlands is frequent, but results in limited onward transmission.
    AIDS. 2021 Oct 5. pii: 00002030-900000000-96312.
    PubMed     Abstract available

  168. SHAIKH K, Bhondoekhan F, Haberlen S, Nakanishi R, et al
    Coronary artery plaque progression and cardiovascular risk scores in men with and without HIV-infection.
    AIDS. 2021 Oct 4. pii: 00002030-900000000-96300.
    PubMed     Abstract available

  169. BOZZI G, Meneri M, Peri AM, Taramasso L, et al
    Starting HIV therapy in patients with mitochondrial disease.
    AIDS. 2021;35:2063-2065.

  170. SARKAR S, Haberlen S, Metkus TS, Kingsley L, et al
    HIV serostatus and incident coronary artery stenosis in men with a baseline zero coronary artery calcium.
    AIDS. 2021;35:2061-2063.

  171. TOMIO A, Lupo J, Blanc M, Epaulard O, et al
    Dynamics of anti-HBs antibody decay in vaccinated people with HIV/AIDS.
    AIDS. 2021;35:2059-2061.

  172. HOOVER JR, Frymus DE, Ifafore-Calfee TA
    Recognizing and supporting health workers to advance and sustain HIV gains: lessons from PEPFAR programmes during the COVID-19 response.
    AIDS. 2021;35:2047-2050.

  173. WEINSTEIN ER, Lee JS, Mendez NA, Harkness A, et al
    HIV/AIDS and aging: the new frontier for HIV/AIDS research and care.
    AIDS. 2021;35:2043-2045.

  174. SANDERS EJ, Agutu CA, Graham SM
    Multiple HIV testing strategies are necessary to end AIDS.
    AIDS. 2021;35:2039-2041.

  175. KOENIG LJ, McKnight-Eily LR
    Achieving national HIV prevention goals: the case for addressing depression and other mental health comorbidities.
    AIDS. 2021;35:2035-2037.

  176. NACCARATO M, Kwee F, Zaltzman J, Fong IW, et al
    Ritonavir-boosted antiretroviral therapy precipitating tacrolimus toxicity in a renal transplant patient: is it time for a priori tacrolimus dosage reduction?
    AIDS. 2021;35:2065-2068.

    September 2021
  177. MOLDT B, Gunthard HF, Workowski KA, Little SJ, et al
    Evaluation of HIV-1 reservoir size and broadly neutralizing antibodies (bNAb) susceptibility in acute ART treated individuals.
    AIDS. 2021 Sep 29. pii: 00002030-900000000-96307.
    PubMed     Abstract available

  178. KYAW NTT, Kumar AMV, Harries AD, Satyanarayana S, et al
    Synergy between low body mass index and hyperglycemia at baseline increases tuberculosis incidence among people living with HIV.
    AIDS. 2021 Sep 29. pii: 00002030-900000000-96306.
    PubMed     Abstract available

  179. BREGER TL, Westreich D, Edmonds A, Edwards JK, et al
    A new smoking cessation "cascade" among women with or at risk for HIV infection.
    AIDS. 2021 Sep 29. pii: 00002030-900000000-96305.
    PubMed     Abstract available

  180. MCMAHON JH, Evans VA, Lau JSY, Symons J, et al
    Neurotoxicity with high dose disulfiram and vorinostat used for HIV latency reversal.
    AIDS. 2021 Sep 29. pii: 00002030-900000000-96304.
    PubMed     Abstract available

  181. ONYANGO DO, Akelo V, van der Sande MAB, Ridzon R, et al
    Causes of death in HIV-infected and HIV-uninfected children in the child health and mortality prevention surveillance study-Kenya.
    AIDS. 2021 Sep 29. pii: 00002030-900000000-96303.
    PubMed     Abstract available

  182. KLINGLER J, Paul N, Laumond G, Schmidt S, et al
    Distinct antibody profiles in HLA-B*57+, HLA-B*57- HIV controllers and chronic progressors.
    AIDS. 2021 Sep 27. pii: 00002030-900000000-96309.
    PubMed     Abstract available

  183. VIEIRA VA, Millar J, Adland E, Muenchhoff M, et al
    Robust HIV-specific CD4+ and CD8+ T-cell responses distinguish the rare phenotype of elite control in adolescents living with HIV from viraemic non-progressors.
    AIDS. 2021 Sep 27. pii: 00002030-900000000-96308.
    PubMed     Abstract available

  184. CAHN P, Madero JS, Arribas JR, Antinori A, et al
    Three-year durable efficacy of dolutegravir plus lamivudine in antiretroviral therapy-naive adults with HIV-1 infection.
    AIDS. 2021 Sep 15. pii: 00002030-900000000-96314.
    PubMed     Abstract available

  185. N'TAKPE JB, Gabillard D, Moh R, Gardiennet E, et al
    Elite and viremic HIV-1 controllers in West Africa.
    AIDS. 2021 Sep 14. pii: 00002030-900000000-96315.
    PubMed     Abstract available

  186. QU Y, Weinstein A, Wang Z, Cheng Y, et al
    Legacy effect on neuropsychological function in HIV-infected men on combination antiretroviral therapy.
    AIDS. 2021 Sep 13. pii: 00002030-900000000-96316.
    PubMed     Abstract available

  187. STENGER MR, Pathela P, Schumacher C, Burghardt N, et al
    Trends in HIV prevalence by self-report among MSM diagnosed and 1 reported with gonorrhea in six U.S. jurisdictions, 2010-2019.
    AIDS. 2021 Sep 10. pii: 00002030-900000000-96317.
    PubMed     Abstract available

  188. CORLEY MJ, Pang APS, Rasmussen TA, Tolstrup M, et al
    Candidate host epigenetic marks predictive for HIV reservoir size, responsiveness to latency reversal, and viral rebound.
    AIDS. 2021 Sep 2. pii: 00002030-900000000-96322.
    PubMed     Abstract available

  189. FRANCO S, Horneros J, Soldevila L, Ouchi D, et al
    Single nucleotide polymorphisms in PNPLA3, ADAR-1, and IFIH1 are associated with advanced liver fibrosis in patients co-infected with HIV-1/HCV.
    AIDS. 2021 Sep 2. pii: 00002030-900000000-96321.
    PubMed     Abstract available

  190. CHOW FC, Callen A, Arechiga V, Saloner D, et al
    Intracranial vascular imaging detects arterial wall abnormalities in persons with treated HIV infection.
    AIDS. 2021 Sep 2. pii: 00002030-900000000-96320.
    PubMed     Abstract available

  191. YAGER JL, Brooks KM, Castillo-Mancilla JR, Nemkov C, et al
    Tenofovir-diphosphate in peripheral blood mononuclear cells during low, medium, and high adherence to F/TAF vs. F/TDF.
    AIDS. 2021 Sep 2. pii: 00002030-900000000-96319.
    PubMed     Abstract available

  192. ABRAHAM AG, Sun J, Sharma A, Yin MT, et al
    The combined effects of age and HIV on the anatomic distribution of cortical and cancellous bone in the femoral neck among men and women.
    AIDS. 2021 Sep 2. pii: 00002030-900000000-96318.
    PubMed     Abstract available

  193. CHAN C, Patel P, Johnson K, Vaughan M, et al
    Community-based peer-led HIV/sexually transmitted infection testing services in Sydney for gay and bisexual men captured an eighth of new HIV diagnoses in New South Wales, Australia.
    AIDS. 2021;35:1878-1880.

  194. WANG Y, Feng R, Xu J, Shi L, et al
    An updated meta-analysis on the association between HIV infection and COVID-19 mortality.
    AIDS. 2021;35:1875-1878.

  195. VANCE DE, Becker JT
    Using HIV neuropsychological classification methods to predict employment status.
    AIDS. 2021;35:1859-1861.

  196. DOSHI RK, Greenberg AE
    Test, treat, and maintain: rapid initiation of antiretroviral therapy.
    AIDS. 2021;35:1867-1869.

  197. CRAWFORD KW, Nathan M
    Anal neoplasia: prevention or treatment?
    AIDS. 2021;35:1863-1865.

  198. SEELEY J
    Social context and tracing household wealth over time in rural Uganda 1994-2018.
    AIDS. 2021;35:1857-1858.

  199. SANTELLI JS, Chen I, Makumbi F, Wei Y, et al
    Household wealth and HIV incidence over time, rural Uganda, 1994-2018.
    AIDS. 2021;35:1835-1843.
    PubMed     Abstract available

  200. CROWELL TA, Daud II, Maswai J, Owuoth J, et al
    SARS-CoV-2 antibody prevalence in people with and without HIV in rural western Kenya, January to March 2020.
    AIDS. 2021 Sep 1. pii: 00002030-900000000-96325.
    PubMed     Abstract available

    August 2021
  201. VISHWANATHAN SA, Zhao C, Luthra R, Khalil GK, et al
    Sexually transmitted infections and depot medroxyprogesterone acetate do not impact protection from SHIV acquisition by long-acting cabotegravir in macaques.
    AIDS. 2021 Aug 20. pii: 00002030-900000000-96329.
    PubMed     Abstract available

  202. DAMAS J, Ledergerber B, Nadin I, Tarr PE, et al
    Neurocognitive course at two-year follow-up in the neurocognitive assessment in the metabolic and aging cohort (NAMACO) study.
    AIDS. 2021 Aug 19. pii: 00002030-900000000-96330.
    PubMed     Abstract available

  203. MARASINI B, Vyas HK, Lakhashe SK, Hariraju D, et al
    Mucosal AIDS virus transmission is enhanced by antiviral IgG isolated early in infection.
    AIDS. 2021 Aug 16. pii: 00002030-900000000-96332.
    PubMed     Abstract available

  204. LLOYD AR, Savage R, Eaton E
    Opioid use disorder: a neglected human immunodeficiency virus risk in American adolescents.
    AIDS. 2021 Aug 13. pii: 00002030-900000000-96331.
    PubMed     Abstract available

  205. PREMEAUX TA, Moser CB, McKhann A, Hoenigl M, et al
    Plasma galectin-9 as a predictor of adverse non-AIDS events in persons with chronic HIV during suppressive antiretroviral therapy.
    AIDS. 2021 Aug 6. pii: 00002030-900000000-96334.
    PubMed     Abstract available

  206. DAH TTE, Yaya I, Mensah E, Coulibaly A, et al
    Rapid antiretroviral therapy initiation and its effect on treatment response in men who have sex with men in West Africa.
    AIDS. 2021 Aug 4. pii: 00002030-900000000-96335.
    PubMed     Abstract available

  207. PASTICCI MB, De Socio GV, Gagliardini R, Merlini E, et al
    Lack of HIV seroconversion in a patient treated immediately with antiretroviral therapy at acute infection and virus relapse.
    AIDS. 2021;35:1708-1710.

  208. MICAN R, Busca Arenzana C, Vasquez J, Daroca G, et al
    Hepatitis B reactivation after tenofovir withdrawal in an HIV-infected patient with history of cured hepatitis B virus infection and poor immunological status.
    AIDS. 2021;35:1707-1708.

  209. VAN HOEK AJ, Reitsema M, Xiridou M, van Sighem A, et al
    Offering a choice of daily and event-driven preexposure prophylaxis for men who have sex with men in the Netherlands: a cost-effectiveness analysis.
    AIDS. 2021;35:1677-1682.
    PubMed     Abstract available

  210. BAUGHER AR, Whiteman A, Jeffries WL 4th, Finlayson T, et al
    Black men who have sex with men living in states with HIV criminalization laws report high stigma, 23 U.S. cities, 2017.
    AIDS. 2021;35:1637-1645.
    PubMed     Abstract available

  211. MILLAR JR, Fatti I, Mchunu N, Bengu N, et al
    Second-generation mother-to-child HIV transmission in South Africa is characterized by poor outcomes.
    AIDS. 2021;35:1597-1604.
    PubMed     Abstract available

  212. PRENDERGAST AJ, Szubert AJ, Pimundu G, Berejena C, et al
    The impact of viraemia on inflammatory biomarkers and CD4+ cell subpopulations in HIV-infected children in sub-Saharan Africa.
    AIDS. 2021;35:1537-1548.
    PubMed     Abstract available

  213. MARCHETTI G, Asmuth D
    Women are from venus: implications for diversified sex-based preexposure prophylaxis approaches.
    AIDS. 2021;35:1691-1693.

    Hepatitis C virus infection and cardiac dysfunction in women.
    AIDS. 2021;35:1689-1690.

    July 2021
  215. MORAKA NO, Garcia-Broncano P, Hu Z, Ajibola G, et al
    Patterns of pre-treatment drug resistance mutations of very early diagnosed and treated infants in botswana.
    AIDS. 2021 Jul 28. pii: 00002030-900000000-96339.
    PubMed     Abstract available

  216. ANDERSON K, Kalk E, Madlala HP, Nyemba DC, et al
    Increased infectious-cause hospitalization among infants who are HIV-exposed uninfected compared to HIV-unexposed.
    AIDS. 2021 Jul 28. pii: 00002030-900000000-96338.
    PubMed     Abstract available

  217. LORENZ DR, Mukerji SS, Misra V, Uno H, et al
    Multimorbidity networks associated with frailty among middle aged and older people with HIV.
    AIDS. 2021 Jul 28. pii: 00002030-900000000-96337.
    PubMed     Abstract available

  218. TOSKA E, Zhou S, Laurenzi CA, Haghighat R, et al
    Predictors of secondary HIV transmission risk in a cohort of adolescents living with HIV in South Africa.
    AIDS. 2021 Jul 28. pii: 00002030-900000000-96336.
    PubMed     Abstract available

  219. WANG M, Boeke CE, Rioja MR, Maparo T, et al
    Feasibility and impact of near-point-of-care integrated TB/HIV testing in Malawi and Zimbabwe.
    AIDS. 2021 Jul 22. pii: 00002030-900000000-96342.
    PubMed     Abstract available

  220. DRAK D, Mcmanus H, Vickers T, Heron JE, et al
    Renal impairment in a large-scale HIV pre-exposure prophylaxis implementation cohort.
    AIDS. 2021 Jul 22. pii: 00002030-900000000-96341.
    PubMed     Abstract available

  221. SEKHAR RV
    Supplementing glycine and N-acetylcysteine (GlyNAC) rapidly improves health-related quality of life and lowers perception of fatigue in patients with HIV.
    AIDS. 2021;35:1522-1524.

  222. PAPAMANOLI A, Psevdos G
    False-positive HIV screening test in a patient with pulmonary embolism because of severe acute respiratory syndrome coronavirus 2 infection.
    AIDS. 2021;35:1521-1522.

  223. DOWNING JM, Prince DJ, Sun CJ
    Prevalence of HIV testing among black and white transgender adults, 2016-2019.
    AIDS. 2021;35:1519-1520.

  224. TAN CS, Reeves RK
    HIV on the brain: is neurosignalling damage irreversible even on antiretroviral therapy?
    AIDS. 2021;35:1503-1504.

  225. IPSER JC, Vera JH
    Does duration of HIV infection substitute for age as a risk factor for amyloid deposition?
    AIDS. 2021;35:1501-1502.

    Circulating micro-RNAs as biomarkers of liver fibrosis progression in hepatitis C virus/HIV-1-co-infected patients: a 'miR'-velous opportunity of early diagnosis?
    AIDS. 2021;35:1499-1500.

    Pediatric liquid 'single tablet regimens' for HIV-a call to action.
    AIDS. 2021;35:1497-1498.

  228. MCBRIDE B, Shannon K, Strathdee SA, Goldenberg SM, et al
    Structural determinants of HIV/STI prevalence, HIV/STI/sexual and reproductive health access, and condom use among immigrant sex workers globally.
    AIDS. 2021;35:1461-1477.
    PubMed     Abstract available

  229. MARUKUTIRA T, Wood BR
    Growing data for recycling tenofovir and lamivudine with dolutegravir as empiric second-line antiretroviral therapy in resource-limited settings.
    AIDS. 2021;35:1505-1507.

  230. RAMOS-RINCON JM, Pinargote H, Ramos-Belinchon C, de Mendoza C, et al
    Hepatitis delta in patients hospitalized in Spain (1997-2018).
    AIDS. 2021 Jul 13. pii: 00002030-900000000-96346.
    PubMed     Abstract available

  231. SWINDELLS S, Lutz T, van Zyl L, Porteiro N, et al
    Long-acting cabotegravir + rilpivirine for HIV-1 treatment: ATLAS week 96 results.
    AIDS. 2021 Jul 13. pii: 00002030-900000000-96345.
    PubMed     Abstract available

  232. GODIN A, Eaton JW, Giguere K, Marsh K, et al
    Inferring population HIV incidence trends from surveillance data of recent HIV infection among HIV testing clients.
    AIDS. 2021 Jul 9. pii: 00002030-900000000-96350.
    PubMed     Abstract available

  233. ASIF S, Baxevanidi E, Hill A, Venter F, et al
    The predicted risk of adverse pregnancy outcomes as a result of treatment-associated obesity in a hypothetical population receiving TAF/FTC/DTG, TDF/FTC/DTG or TDF/FTC/EFV.
    AIDS. 2021 Jul 9. pii: 00002030-900000000-96351.
    PubMed     Abstract available

  234. RUDDY JA, Boyarsky BJ, Bailey JR, Karaba AH, et al
    Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV.
    AIDS. 2021 Jul 8. pii: 00002030-900000000-96349.
    PubMed     Abstract available

  235. VYAS P, Mathad JS, Leu CS, Naik S, et al
    Impact of HIV status on systemic inflammation during pregnancy.
    AIDS. 2021 Jul 8. pii: 00002030-900000000-96348.
    PubMed     Abstract available

  236. AKGUN KM, Krishnan S, Butt AA, Gibert CL, et al
    HIV-infected medical ICU (MICU) survivors without CD4 cell recovery are at increased risk for poor outcomes regardless of viral suppression in a national cohort.
    AIDS. 2021 Jul 8. pii: 00002030-900000000-96347.
    PubMed     Abstract available

  237. RONCHETTI AM, Matheron S, Galicier L, Damond F, et al
    Lymphoma in HIV-2-infected patients in combination antiretroviral therapy era.
    AIDS. 2021 Jul 6. pii: 00002030-900000000-96352.
    PubMed     Abstract available

  238. MACPHAIL AI, McLean C, Vujovic O, Hoy JF, et al
    A 44-year-old man with an ulcerating skin rash in the setting of advanced human immunodeficiency virus infection.
    AIDS. 2021;35:1325-1326.

  239. LASRY A, Baker-Goering M
    Cost analyses of HIV treatment should be standardized and report cost drivers.
    AIDS. 2021;35:1311-1312.

  240. DASH PK, Akay-Espinoza C
    FDG PET/computed tomography can detect region-specific neuronal changes following antiretroviral therapy in HIV-infected patients.
    AIDS. 2021;35:1309-1310.

  241. DASH PK, Boix V
    Fixed-dose darunavir/cobicistat in pregnancy of HIV-infected women, pharmacokinetic concerns.
    AIDS. 2021;35:1301-1303.

  242. VELDSMAN KA, Laughton B, Janse van Rensburg A, Zuidewind P, et al
    Viral suppression is associated with HIV-antibody level and HIV-1 DNA detectability in early treated children at 2 years of age.
    AIDS. 2021;35:1247-1252.
    PubMed     Abstract available

  243. IMBERT E, Hickey MD, Clemenzi-Allen A, Lynch E, et al
    Evaluation of the POP-UP programme: a multicomponent model of care for people living with HIV with homelessness or unstable housing.
    AIDS. 2021;35:1241-1246.
    PubMed     Abstract available

  244. MOMPER JD, Wang J, Stek A, Shapiro DE, et al
    Pharmacokinetics of darunavir and cobicistat in pregnant and postpartum women with HIV.
    AIDS. 2021;35:1191-1199.
    PubMed     Abstract available

  245. CATTANEO D, Bernacchia D, Beltrami M, Resnati C, et al
    When the absence of an interaction can become clinically relevant.
    AIDS. 2021;35:1327-1328.

  246. WOOD BR, Pozniak AL
    Dosing lamivudine or emtricitabine in renal impairment: new data confirm it's time for updated guidance!
    AIDS. 2021;35:1305-1307.

  247. KANNO Y, Hau TTT, Kurokawa R, Nomura T, et al
    Late-phase dominance of a single epitope-specific CD8+ T-cell response in passive neutralizing antibody-infused SIV controllers.
    AIDS. 2021 Jul 1. pii: 00002030-900000000-96355.
    PubMed     Abstract available

  248. JIJ OACUTE N SIA, Molina JM, Costagliola D, Supervie V, et al
    Can HIV epidemics among men who have sex with men be eliminated through participation in PrEP rollouts?
    AIDS. 2021 Jul 1. pii: 00002030-900000000-96354.
    PubMed     Abstract available

  249. MWASAKIFWA GE, Amin J, Kelleher A, Boyd MA, et al
    Inflammatory biomarker and soft tissue changes among patients commencing second-line ART after first-line virological failure.
    AIDS. 2021 Jul 1. pii: 00002030-900000000-96353.
    PubMed     Abstract available

    June 2021
  250. SANTOS JCV, Orsi JSR, Ribeiro VS, Tuon FF, et al
    The challenging of HIV care one year after of COVID-19 pandemic: results from a Brazilian cohort.
    AIDS. 2021 Jun 25. pii: 00002030-900000000-96357.

  251. GILMORE JC, Zhang G, Cameron DW, Serghides L, et al
    Impact of in utero antiretroviral drug exposure on expression of membrane-associated transporters in mouse placenta and fetal brain.
    AIDS. 2021 Jun 25. pii: 00002030-900000000-96356.
    PubMed     Abstract available

  252. LESKO CR, Hutton HE, Fojo AT, Shen NM, et al
    Depression and HIV viral non-suppression among people engaged in HIV care in an urban clinic, 2014-2019.
    AIDS. 2021 Jun 24. pii: 00002030-900000000-96361.
    PubMed     Abstract available

  253. LIU G, Mugo NR, Brown ER, Mgodi NM, et al
    Prevalent HPV infection increases the risk of HIV acquisition in African women: advancing the argument for HPV immunization.
    AIDS. 2021 Jun 24. pii: 00002030-900000000-96360.
    PubMed     Abstract available

  254. BURKE RM, Henrion MYR, Mallewa J, Masamba L, et al
    Incidence of HIV-positive admission and inpatient mortality in Malawi [2012-2019]: a population cohort study.
    AIDS. 2021 Jun 24. pii: 00002030-900000000-96359.
    PubMed     Abstract available

  255. CREPAZ N, Song R, Lyss S, Hall HI, et al
    Estimated time from HIV infection to diagnosis and diagnosis to first viral suppression during 2014-2018.
    AIDS. 2021 Jun 24. pii: 00002030-900000000-96358.
    PubMed     Abstract available

  256. MHLEKUDE B, Lenman A, Sidoyi P, Joseph J, et al
    The barrier functions of crude cervical mucus plugs against HIV-1 infection in the context of cell-free and cell-to-cell transmission.
    AIDS. 2021 Jun 21. pii: 00002030-900000000-96362.
    PubMed     Abstract available

  257. KREBS E, Enns E, Zang X, Mah CS, et al
    Attributing health benefits to preventing HIV infections versus improving health outcomes among people living with HIV: an analysis in six US cities.
    AIDS. 2021 Jun 18. pii: 00002030-900000000-96365.
    PubMed     Abstract available

  258. SUZUKI K, Levert A, Yeung J, Starr M, et al
    HIV-1 viral blips are associated with repeated and increasingly high levels of cell-associated HIV-1 RNA transcriptional activity.
    AIDS. 2021 Jun 18. pii: 00002030-900000000-96364.
    PubMed     Abstract available

  259. ROWLINSON E, Mawandia S, Ledikwe J, Bakae O, et al
    HIV testing criteria to reduce testing volume and increase positivity in Botswana.
    AIDS. 2021 Jun 16. pii: 00002030-900000000-96367.
    PubMed     Abstract available

  260. ZIMBA S, Nutakki A, Chishimba L, Chomba M, et al
    Risk factors and outcomes of HIV-associated stroke in Zambia.
    AIDS. 2021 Jun 16. pii: 00002030-900000000-96366.
    PubMed     Abstract available

  261. CHAN TY, De Zan V, Gregg A, Alagaratnam J, et al
    Cerebrospinal fluid HIV RNA escape symptomatology.
    AIDS. 2021 Jun 15. pii: 00002030-900000000-96370.
    PubMed     Abstract available

  262. GRANGER LA, Huettner I, Debeljak F, Kaleebu P, et al
    Broadly neutralizing antibody responses in the longitudinal primary HIV-1 infection SPARTAC cohort.
    AIDS. 2021 Jun 14. pii: 00002030-900000000-96373.
    PubMed     Abstract available

  263. MORROW M, Mawhinney S, Coyle RP, Coleman SS, et al
    Emtricitabine triphosphate in dried blood spots predicts future viremia in persons with HIV and identifies mismatch with self-reported adherence.
    AIDS. 2021 Jun 14. pii: 00002030-900000000-96372.
    PubMed     Abstract available

  264. FAJNZYLBER J, Sharaf R, Hutchinson JN, Aga E, et al
    Frequency of Post Treatment Control Varies by ART Restart and Viral Load Criteria.
    AIDS. 2021 Jun 14. pii: 00002030-900000000-96371.
    PubMed     Abstract available

  265. SHEN Y, Shiau S, Strehlau R, Burke M, et al
    Persistently lower bone mass and bone turnover among south african children living with well-controlled HIV.
    AIDS. 2021 Jun 14. pii: 00002030-900000000-96369.
    PubMed     Abstract available

  266. GENBERG BL, Wilson-Barthes MG, Omodi V, Hogan JW, et al
    Microfinance, retention in care, and mortality among patients enrolled in HIV 2 Care in East Africa.
    AIDS. 2021 Jun 10. pii: 00002030-900000000-96376.
    PubMed     Abstract available

  267. CLAYTOR JD, Viramontes O, Conner S, Wen KW, et al
    TNF-alpha inhibition in the setting of undiagnosed HIV infection: a call for enhanced screening guidelines.
    AIDS. 2021 Jun 10. pii: 00002030-900000000-96375.
    PubMed     Abstract available

  268. NDUATI EW, Gorman MJ, Sein Y, Hermanus T, et al
    Coordinated Fc-effector and neutralization functions in HIV-infected children define a window of opportunity for HIV vaccination.
    AIDS. 2021 Jun 10. pii: 00002030-900000000-96374.
    PubMed     Abstract available

  269. NWOGU JN, Gandhi M, Owen A, Khoo S, et al
    Associations between efavirenz concentrations, pharmacogenetics, and neurocognitive performance in people living with HIV in Nigeria.
    AIDS. 2021 Jun 9. pii: 00002030-900000000-96381.
    PubMed     Abstract available

  270. ROLLE CP, Berhe M, Singh T, Ortiz R, et al
    Dolutegravir/lamivudine as a first-line regimen in a test-and-treat setting for newly diagnosed people living with HIV.
    AIDS. 2021 Jun 9. pii: 00002030-900000000-96380.
    PubMed     Abstract available

  271. HEATH K, Levi J, Hill A
    Reaching UNAIDS 95-95-95 targets worldwide: predicted benefits and treatment costs with generic manufacture.
    AIDS. 2021 Jun 9. pii: 00002030-900000000-96379.
    PubMed     Abstract available

  272. ROBERTSON J, Eden A, Nystrom K, Hagberg L, et al
    Increased immune activation and signs of neuronal injury in HIV-negative people on pre-exposure prophylaxis (PrEP).
    AIDS. 2021 Jun 9. pii: 00002030-900000000-96378.
    PubMed     Abstract available

  273. KOEHN K, Cassidy-Matthews C, Pearce M, Aspin C, et al
    Rates of new HIV diagnoses among Indigenous peoples in Canada, Australia, New Zealand, and the United States: 2009-2017.
    AIDS. 2021 Jun 9. pii: 00002030-900000000-96377.
    PubMed     Abstract available

  274. GABRIEL EM, Salinas TRW, Gosselin A, Larouche-Anctil E, et al
    Overt IL-32 Isoform Expression at Intestinal Level during HIV-1 Infection is Negatively Regulated by IL-17A.
    AIDS. 2021 Jun 7. pii: 00002030-900000000-96384.
    PubMed     Abstract available

  275. HERRERA C, Harman S, Aldon Y, Rogers P, et al
    The entry inhibitor DS003 (BMS-599793), a BMS-806 analogue, provides superior activity as a pre-exposure prophylaxis candidate.
    AIDS. 2021 Jun 7. pii: 00002030-900000000-96382.
    PubMed     Abstract available

  276. ANDREIA A, Cappello C, Stirrup O
    High-risk hpv, precancerous lesions and cancer in anal condylomas: systematic review and meta-analysis.
    AIDS. 2021 Jun 7. pii: 00002030-900000000-96383.
    PubMed     Abstract available

  277. GUARDIGNI V, Toschi A, Badia L, Del Turco ER, et al
    Patients living with HIV and cirrhosis: the risk for hepatocellular carcinoma after direct-acting antivirals for HCV.
    AIDS. 2021 Jun 4. pii: 00002030-900000000-96387.
    PubMed     Abstract available

  278. JIN F, Amin J, Guy R, Vaccher S, et al
    Adherence to daily HIV Pre-exposure prophylaxis in a large-scale implementation study in New South Wales, Australia.
    AIDS. 2021 Jun 4. pii: 00002030-900000000-96386.
    PubMed     Abstract available

  279. MAKADZANGE TA, Hlupeni A, Machekano R, Boyd K, et al
    Survival following screening and preemptive antifungal therapy for subclinical cryptococcal disease in advanced HIV infection.
    AIDS. 2021 Jun 4. pii: 00002030-900000000-96385.
    PubMed     Abstract available

  280. PETERSON M, Sarita Shah N, Smith-Jeffcoat SE, Nichols C, et al
    Global progress and gaps in tuberculosis screening and treatment among people with HIV: experience from 32 countries.
    AIDS. 2021;35:1154-1156.

  281. NIGHTINGALE S, Dreyer AJ, Gisslen M, Winston A, et al
    Response to: Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study period.
    AIDS. 2021;35:1152-1153.

  282. WIERSINGA WJ, van der Valk M
    Severe coronavirus disease 2019 in a patient with HIV-2 infection.
    AIDS. 2021;35:1151-1152.

  283. VIEIRA VA, Fairlie L
    Effects of preconception antiretroviral therapy in placenta development and pregnancy outcomes.
    AIDS. 2021;35:1139-1141.

  284. ROMANELLI A, Moore D
    The importance of wearables: sleep assessment devices for people with HIV.
    AIDS. 2021;35:1137-1138.

    Disregarding drug resistance mutations without peril.
    AIDS. 2021;35:1135-1136.

  286. BOYD AT, Ogbanufe O, Onyenuobi C, Mgbakor I, et al
    Scale-up of antiretroviral treatment access among people living with HIV in Rivers State, Nigeria, 2019--2020.
    AIDS. 2021;35:1127-1134.
    PubMed     Abstract available

  287. BOURDON M, Garnier A, Maignien C, Marcellin L, et al
    Assisted reproductive technology outcomes in women with a chronic viral disease.
    AIDS. 2021;35:1073-1081.
    PubMed     Abstract available

  288. ACKERMAN P, Thompson M, Molina JM, Aberg J, et al
    Long-term efficacy and safety of fostemsavir among subgroups of heavily treatment-experienced adults with HIV-1.
    AIDS. 2021;35:1061-1072.
    PubMed     Abstract available

  289. PENG AT, Huang SH, Sun HY, Huang YC, et al
    Use of dietary supplements containing polyvalent cations and antacids among people living with HIV and its impact on viral suppression.
    AIDS. 2021 Jun 1. pii: 00002030-900000000-96390.
    PubMed     Abstract available

  290. HAMEIRI-BOWEN D, Sovershaeva E, Flaegstad T, Gutteberg TJ, et al
    Soluble biomarkers associated with chronic lung disease in older children and adolescents with perinatal HIV infection.
    AIDS. 2021 Jun 1. pii: 00002030-900000000-96389.
    PubMed     Abstract available

  291. APARICIO JM, Xu Y, Li Y, Colantuoni C, et al
    Plasma microRNAs are associated with domain-specific cognitive function in people with HIV.
    AIDS. 2021 Jun 1. pii: 00002030-900000000-96388.
    PubMed     Abstract available

    May 2021
  292. BADE AN, Gendelman HE, McMillan J, Liu Y, et al
    Chemical exchange saturation transfer for detection of antiretroviral drugs in brain tissue.
    AIDS. 2021 May 27. pii: 00002030-900000000-96396.
    PubMed     Abstract available

  293. STIER EA, Engels E, Horner MJ, Robinson B, et al
    Cervical cancer incidence stratified by age in women living with HIV compared with the general population in the United States, 2002-2016.
    AIDS. 2021 May 27. pii: 00002030-900000000-96395.
    PubMed     Abstract available

  294. PAPASAVVAS E, Azzoni L, Ross BN, Fair M, et al
    Comparable HIV suppression by pegylated-IFN-alpha2a or pegylated-IFN-alpha2b during a 4-week analytical treatment interruption.
    AIDS. 2021 May 27. pii: 00002030-900000000-96394.
    PubMed     Abstract available

    Malignancies among children and young people with HIV in Western and Eastern Europe and Thailand.
    AIDS. 2021 May 27. pii: 00002030-900000000-96393.
    PubMed     Abstract available

  296. CORMA-GOMEZ A, Macias J, Tellez F, Morano L, et al
    Kinetics of emergence of liver complications in HCV-infected patients and advanced fibrosis, with and without HIV-coinfection, after SVR.
    AIDS. 2021 May 27. pii: 00002030-900000000-96392.
    PubMed     Abstract available

  297. YU X, Westra JR, Giordano TP, Berenson AB, et al
    Assessing comorbidities and survival in HIV-infected and uninfected matched Medicare enrollees.
    AIDS. 2021 May 27. pii: 00002030-900000000-96391.
    PubMed     Abstract available

  298. TEMU TM, Wagoner J, Masyuko S, O'Connor A, et al
    Central obesity is a contributor to systemic inflammation and monocyte activation in virally suppressed adults with chronic HIV in Kenya.
    AIDS. 2021 May 24. pii: 00002030-900000000-96400.
    PubMed     Abstract available

  299. KOWALSKA JD, Pelchen-Matthews A, Ryom L, Losso MH, et al
    Prevalence and outcomes of pregnancies in women living with HIV over a 20-year period: The EuroSIDA study, 1996 to 2015.
    AIDS. 2021 May 24. pii: 00002030-900000000-96399.
    PubMed     Abstract available

  300. NOVITSKY V, Steingrimsson J, Howison M, Dunn C, et al
    Longitudinal typing of molecular HIV clusters in a statewide epidemic.
    AIDS. 2021 May 24. pii: 00002030-900000000-96398.
    PubMed     Abstract available

  301. TU W, Johnson E, Fujiwara E, Gill MJ, et al
    Predictive variables for peripheral neuropathy in treated HIV-1 infection revealed by machine learning.
    AIDS. 2021 May 24. pii: 00002030-900000000-96397.
    PubMed     Abstract available

  302. VAN GINDERDEUREN E, Bassett J, Hanrahan CF, Mutunga L, et al
    High conversion of tuberculin skin tests during the first year of ART among South African adults in primary care.
    AIDS. 2021 May 19. pii: 00002030-900000000-96402.
    PubMed     Abstract available

  303. SILVERA R, Martinson T, Gaisa MM, Liu Y, et al
    The other side of screening: predictors of treatment and follow-up for anal precancers in a large health system.
    AIDS. 2021 May 19. pii: 00002030-900000000-96401.
    PubMed     Abstract available

  304. VAN DEN ELSHOUT MAM, Hoornenborg E, Achterbergh RCA, Coyer L, et al
    Improving adherence to daily PrEP among MSM in Amsterdam by providing feedback via a mobile application.
    AIDS. 2021 May 17. pii: 00002030-900000000-96403.
    PubMed     Abstract available

  305. PASTORI C, Galli L, Siracusano G, Spagnuolo V, et al
    Serum IgG1 and IgG4 could contribute to partial control of viral rebound in chronically HIV-1 infected subjects.
    AIDS. 2021 May 14. pii: 00002030-900000000-96404.
    PubMed     Abstract available

  306. RUDDY JA, Boyarsky BJ, Werbel WA, Bailey JR, et al
    Safety and antibody response to the first dose of SARS-CoV-2 messenger RNA vaccine in persons with HIV.
    AIDS. 2021 May 14. pii: 00002030-900000000-96405.
    PubMed     Abstract available

  307. DHAIRYAWAN R, Okhai H, Hill T, Sabin CA, et al
    Differences in HIV clinical outcomes amongst heterosexuals in the United Kingdom by ethnicity.
    AIDS. 2021 May 10. pii: 00002030-900000000-96411.
    PubMed     Abstract available

  308. HAMADY A, Cooke GS, Garvey LJ
    Identification of hepatitis delta superinfection when investigating transaminitis in HIV/HBV coinfection.
    AIDS. 2021 May 10. pii: 00002030-900000000-96410.
    PubMed     Abstract available

  309. CHADWICK D, Forbes G, Lawrence C, Lorrimer S, et al
    Using an electronic health record alert to prompt blood-borne virus testing in primary care.
    AIDS. 2021 May 10. pii: 00002030-900000000-96408.
    PubMed     Abstract available

  310. PATHELA P, Jamison K, Braunstein SL, Borges CM, et al
    Initiating antiretroviral treatment for newly diagnosed HIV patients in sexual health clinics greatly improves timeliness of viral suppression.
    AIDS. 2021 May 10. pii: 00002030-900000000-96407.
    PubMed     Abstract available

  311. KEENE CM, Griesel R, Zhao Y, Gcwabe Z, et al
    Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line in adults failing a tenofovir-based first-line regimen: a prospective cohort study.
    AIDS. 2021 May 10. pii: 00002030-900000000-96409.
    PubMed     Abstract available

  312. MACHINGURA F, Chabata S, Busza J, Jamali G, et al
    Potential reduction in female sex workers' risk of contracting HIV during Covid-19.
    AIDS. 2021 May 7. pii: 00002030-900000000-96406.
    PubMed     Abstract available

  313. ROYSTON L, Isnard S, Calmy A, Routy JP, et al
    Kaposi sarcoma in ART-treated people living with HIV: A wake-up call for research on HHV-8.
    AIDS. 2021 May 5. pii: 00002030-900000000-96414.

  314. GARBER DA, Guenthner P, Mitchell J, Ellis S, et al
    Broadly neutralizing antibody-mediated protection of macaques against repeated intravenous exposures to simian-human immunodeficiency virus.
    AIDS. 2021 May 5. pii: 00002030-900000000-96412.
    PubMed     Abstract available

  315. GOSENS KCM, van der Zee RP, van Heukelom MLS, Jongen VW, et al
    HPV vaccination to prevent recurrence of Anal Intraepithelial Neoplasia in HIV+ MSM: a randomised, placebo-controlled multicentre trial.
    AIDS. 2021 May 5. pii: 00002030-900000000-96413.
    PubMed     Abstract available

  316. KUMWENDA T, Buleya S, Matanje B, Heller T, et al
    Cardiovascular risk assessment for primary prevention in Malawian HIV patients on ART: are measurements of glycated hemoglobin and lipids worth the effort?
    AIDS. 2021;35:997-999.

  317. LAPARRA A, Lerolle N, Gerin M, Cheret A, et al
    Tumor necrosis factor-alpha inhibitors for extended or severe neurological immune reconstitution inflammatory syndrome in HIV-infected patients.
    AIDS. 2021;35:995-997.

  318. TARAMASSO L, Stapleton JT, Siedner MJ
    Weight gain and aging in people with HIV.
    AIDS. 2021;35:987-989.

    Maternal HIV infection and antiretroviral exposure during pregnancy in fetuses and newborns: when solving one problem opens up a Pandora's box of new conundrums.
    AIDS. 2021;35:985-986.

  320. ANDERSON K, Kalk E, Madlala HP, Nyemba DC, et al
    Preterm birth and severe morbidity in hospitalized neonates who are HIV exposed and uninfected compared with HIV unexposed.
    AIDS. 2021;35:921-931.
    PubMed     Abstract available

  321. SHADE SB, Osmand T, Kwarisiima D, Brown LB, et al
    Costs of integrating hypertension care into HIV care in rural East African clinics.
    AIDS. 2021;35:911-919.
    PubMed     Abstract available

  322. LEAL VNC, Reis EC, Fernandes FP, Soares JLDS, et al
    Common pathogen-associated molecular patterns induce the hyper-activation of NLRP3 inflammasome in circulating B lymphocytes of HIV-infected individuals.
    AIDS. 2021;35:899-910.
    PubMed     Abstract available

  323. CHAN MS, Morales A, Zlotorzynska M, Sullivan P, et al
    Estimating the influence of Twitter on pre-exposure prophylaxis use and HIV testing as a function of rates of men who have sex with men in the United States.
    AIDS. 2021;35.
    PubMed     Abstract available

  324. LI Z, Qiao S, Jiang Y, Li X, et al
    Building a social media-based HIV risk behavior index to inform the prediction of HIV new diagnosis: a feasibility study.
    AIDS. 2021;35.
    PubMed     Abstract available

  325. ZHENG C, Wang W, Young SD
    Identifying HIV-related digital social influencers using an iterative deep learning approach.
    AIDS. 2021;35.
    PubMed     Abstract available

  326. WANG B, Liu F, Deveaux L, Ash A, et al
    Adolescent HIV-related behavioural prediction using machine learning: a foundation for precision HIV prevention.
    AIDS. 2021;35.
    PubMed     Abstract available

  327. ZENG C, Zhang J, Sun X, Li Z, et al
    County-level predictors of retention in care status among people living with HIV in South Carolina from 2010 to 2016: a data-driven approach.
    AIDS. 2021;35.
    PubMed     Abstract available

  328. YANG X, Zhang J, Chen S, Weissman S, et al
    Utilizing electronic health record data to understand comorbidity burden among people living with HIV: a machine learning approach.
    AIDS. 2021;35.
    PubMed     Abstract available

  329. CHEN S, Owolabi Y, Dulin M, Robinson P, et al
    Applying a machine learning modelling framework to predict delayed linkage to care in patients newly diagnosed with HIV in Mecklenburg County, North Carolina, USA.
    AIDS. 2021;35.
    PubMed     Abstract available

  330. OLATOSI B, Sun X, Chen S, Zhang J, et al
    Application of machine-learning techniques in classification of HIV medical care status for people living with HIV in South Carolina.
    AIDS. 2021;35.
    PubMed     Abstract available

  331. WEISSMAN S, Yang X, Zhang J, Chen S, et al
    Using a machine learning approach to explore predictors of healthcare visits as missed opportunities for HIV diagnosis.
    AIDS. 2021;35.
    PubMed     Abstract available

  332. OLATOSI B, Vermund SH, Li X
    Power of Big Data in ending HIV.
    AIDS. 2021;35.
    PubMed     Abstract available

  333. HASSOLD N, Baltes V, Martin A, Mechai F, et al
    Hemorrhagic cystitis from BK virus in a patient with AIDS.
    AIDS. 2021;35:999-1001.

    April 2021
  334. BROUILLETTE MJ, Koski L, Forcellino L, Gasparri J, et al
    Predicting occupational outcomes from neuropsychological test performance in older people with HIV.
    AIDS. 2021 Apr 28. pii: 00002030-900000000-96417.
    PubMed     Abstract available

  335. HUNG R, Patel N, Fox J, Cosgrove C, et al
    Prevalence of HIV/hepatitis B and HIV/hepatitis C coinfection among people of East, South, Central and West African ancestry in the United Kingdom.
    AIDS. 2021 Apr 28. pii: 00002030-900000000-96416.
    PubMed     Abstract available

  336. MCCANN K, Shah S, Hindley L, Hill A, et al
    Implications of weight gain with newer antiretrovirals: 10-year predictions of cardiovascular disease and diabetes.
    AIDS. 2021 Apr 28. pii: 00002030-900000000-96415.
    PubMed     Abstract available

  337. DIRAJLAL-FARGO S, Sattar A, Yu J, Albar Z, et al
    Lipidome Association with Vascular Disease and Inflammation in HIV+ Ugandan Children.
    AIDS. 2021 Apr 19. pii: 00002030-900000000-96419.
    PubMed     Abstract available

  338. SLAMA L, Barrett BW, Abraham AG, Palella FJ Jr, et al
    Risk for incident diabetes is greater in pre-diabetic men with HIV than without HIV.
    AIDS. 2021 Apr 15. pii: 00002030-900000000-96422.
    PubMed     Abstract available

  339. SHITOLE SG, Lazar JM, Hanna DB, Kim RS, et al
    HIV, HCV and risk of new-onset left ventricular dysfunction: the women's interagency HIV study.
    AIDS. 2021 Apr 15. pii: 00002030-900000000-96421.
    PubMed     Abstract available

  340. LAU JSY, McMahon JH, Gubser C, Solomon A, et al
    The impact of immune checkpoint therapy on the latent reservoir in HIV infected individuals with cancer on antiretroviral therapy.
    AIDS. 2021 Apr 15. pii: 00002030-900000000-96420.
    PubMed     Abstract available

  341. KALMIN MM, Westreich D, Drummond BM, Sun J, et al
    Incident obstructive lung disease and mortality among HIV-positive and negative persons with a history of injecting drugs.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96436.
    PubMed     Abstract available

  342. SANDAMANN L, Stoll M, Behrens GMN
    Hypophosphatemia in people living with HIV: No benefit when switching from TDF to TAF.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96435.
    PubMed     Abstract available

  343. SEKABIRA R, Mcgowan I, Yuhas K, Brand RM, et al
    Higher colorectal tissue HIV infectivity in cisgender women compared with MSM before and during oral preexposure prophylaxis.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96434.
    PubMed     Abstract available

  344. JENNESS SM, Knowlton G, Smith DK, Marcus JL, et al
    A decision analytics model to optimize investment in interventions targeting the HIV PrEP cascade of care.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96433.
    PubMed     Abstract available

  345. GIANOTTI N, Galli L, Poli A, Torre LD, et al
    Residual viremia in HIV-infected patients who continue a 2-drug or switch to a 3-drug integrase strand transfer inhibitor-based regimen.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96432.
    PubMed     Abstract available

  346. SADOUNI M, Durand M, Boldeanu I, Danielli C, et al
    Association of Epicardial Fat with Non-Calcified Coronary Plaque Volume and With Low Attenuation Plaque in People Living with HIV.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96431.
    PubMed     Abstract available

  347. KARIUKI SM, Selhorst P, Abrahams MR, Rebe K, et al
    Neutralization sensitivity of genital tract HIV-1: shift in selective milieu shapes the population available to transmit.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96430.
    PubMed     Abstract available

  348. BASTARD JP, Pelloux V, Alili R, Fellahi S, et al
    Altered subcutaneous adipose tissue parameters after switching ART-controlled HIV+ patients to raltegravir/maraviroc.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96429.
    PubMed     Abstract available

  349. APORNPONG T, Grinsztejn B, Hughes M, Ritz J, et al
    Antiretroviral Hair Levels, Self-Reported Adherence and Virologic Failure in Second-Line Regimen Patients in Resource-Limited Settings.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96428.
    PubMed     Abstract available

  350. MACBRAYNE CE, Rutstein RM, Wiznia AA, Graham B, et al
    Etravirine in treatment-experienced HIV-1 infected children 1-<6 years of age.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96427.
    PubMed     Abstract available

  351. FEINSTEIN MJ, Haberlen SA, Ashikaga H, Palella FJ, et al
    Ventricular ectopy and arrhythmia by HIV serostatus, viremia, and CD4+ cell count.
    AIDS. 2021;35:846-849.

  352. PREININGER L, Kahal DA, Szabo S
    Hepatitis B vaccination response and safety in people living with HIV/AIDS receiving HepB-CpG series.
    AIDS. 2021;35:845-846.

  353. DRAK D, Dahwa R, Reakes E, Heron JE, et al
    Baseline renal function predicts mortality in adolescents commenced on HIV antiretroviral therapy.
    AIDS. 2021;35:843-845.

  354. IKUMI NM, Malaba TR, Pillay K, Cohen MC, et al
    Differential impact of antiretroviral therapy initiated before or during pregnancy on placenta pathology in HIV-positive women.
    AIDS. 2021;35:717-726.
    PubMed     Abstract available

  355. STECHER C, Linnemayr S
    Promoting antiretroviral therapy adherence habits: a synthesis of economic and psychological theories of habit formation.
    AIDS. 2021;35:711-716.

    March 2021
  356. FRANCO S, Buccione D, Tural C, Martinez MA, et al
    Circulating microRNA signatures that predict liver fibrosis progression in patients with HIV-1/HCV co-infections.
    AIDS. 2021 Mar 31. pii: 00002030-900000000-96441.
    PubMed     Abstract available

  357. BERGLOV A, Moseholm E, Katzenstein TL, Johansen IS, et al
    Prevalence and association with birth outcomes of low Vitamin D levels among pregnant women living with HIV.
    AIDS. 2021 Mar 31. pii: 00002030-900000000-96440.
    PubMed     Abstract available

  358. MORGELLO S, Cortes EP, Gensler G, Meloni G, et al
    HIV disease duration, but not active brain infection, predicts cortical amyloid beta deposition.
    AIDS. 2021 Mar 31. pii: 00002030-900000000-96439.
    PubMed     Abstract available

  359. RAVA M, Bisbal O, Dominguez-Dominguez L, Aleman MR, et al
    Late presentation for HIV impairs immunological but not virological response to antiretroviral treatment.
    AIDS. 2021 Mar 31. pii: 00002030-900000000-96438.
    PubMed     Abstract available

  360. MAXI JK, Foret BL, Amedee A, Mcdaniel LS, et al
    ART administration reduces neuroinflammation without restoring BDNF signaling in alcohol-administered SIV-infected macaques.
    AIDS. 2021 Mar 31. pii: 00002030-900000000-96437.
    PubMed     Abstract available

  361. COLLINS LF, Shantha JG, Nesper PL, Sheth AN, et al
    Assessment of retinal microvascular health by optical coherence tomography angiography among persons with HIV.
    AIDS. 2021 Mar 23. pii: 00002030-900000000-96442.
    PubMed     Abstract available

  362. GROVE M, Brown LL, Knudsen HK, Martin EG, et al
    Employing telehealth within HIV care: Advantages, challenges, and recommendations.
    AIDS. 2021 Mar 22. pii: 00002030-900000000-96447.

  363. LIN SH, Wang Y, Hartley SW, Karyadi DM, et al
    In utero exposure to zidovudine-containing antiretroviral therapy and clonal hematopoiesis in HIV-exposed uninfected newborns.
    AIDS. 2021 Mar 22. pii: 00002030-900000000-96446.
    PubMed     Abstract available

  364. SMITH T, Masciotra S, Luo W, Sullivan V, et al
    Broadly neutralizing HIV-1 antibody reactivity in HIV tests: implications for diagnostics.
    AIDS. 2021 Mar 22. pii: 00002030-900000000-96445.
    PubMed     Abstract available

  365. LAKE JE, LA K, Erlandson KM, Adrian S, et al
    Tesamorelin Improves Fat Quality Independent of Changes in Fat Quantity.
    AIDS. 2021 Mar 22. pii: 00002030-900000000-96444.
    PubMed     Abstract available

  366. TRAN H, Saleem K, Lim M, Chow EPF, et al
    Global estimates for the lifetime cost of managing HIV: a systematic review.
    AIDS. 2021 Mar 22. pii: 00002030-900000000-96443.
    PubMed     Abstract available

  367. JAO J, Jacobson DL, Russell JS, Wang J, et al
    Perinatally acquired HIV infection is associated with abnormal blood mitochondrial function during childhood/adolescence.
    AIDS. 2021 Mar 16. pii: 00002030-900000000-96451.
    PubMed     Abstract available

  368. CUTRELL AG, Schapiro JM, Perno CF, Kuritzkes DR, et al
    Predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis across three phase 3 studies.
    AIDS. 2021 Mar 16. pii: 00002030-900000000-96450.
    PubMed     Abstract available

  369. CLUVER L, Shenderovich Y, Toska E, Rudgard WE, et al
    Clinic and care: associations with adolescent ART adherence in a prospective cohort in South Africa.
    AIDS. 2021 Mar 16. pii: 00002030-900000000-96449.
    PubMed     Abstract available

  370. NGUYEN PT, Gilmour S, Le PM, Onishi K, et al
    Progress toward HIV elimination goals: trends in and projections of Annual HIV testing and condom use in Africa.
    AIDS. 2021 Mar 16. pii: 00002030-900000000-96448.
    PubMed     Abstract available

  371. BUTEL-SIMOES G, Woolley I, McMahon J, Yeo A, et al
    IgG4-related disease masquerading as a fungating groin lesion in a patient with HIV and incomplete immune reconstitution.
    AIDS. 2021;35:706-707.

  372. HIREMATH PM, Suri D, Arora K, Shandilya J, et al
    Human leukocyte antigen B27 and B57 alleles in HIV-infected long-term nonprogressor children.
    AIDS. 2021;35:703-705.

  373. AGWU AL, Flynn PM
    Increasing the urgency to identify adolescents and young adults with HIV infection...do or die.
    AIDS. 2021;35:693-695.

  374. LURAIN K, Mbulaiteye SM
    Does HIV undermine breast cancer outcomes in women?
    AIDS. 2021;35:689-690.

  375. KOJIMA N, Klausner JD
    Preexposure prophylaxis is effective on a national level, but is it enough.
    AIDS. 2021;35:691-692.

  376. METSU D, Aquilina C, Delobel P, Gandia P, et al
    Maraviroc exposure is influenced by exogenous thyrotoxicosis.
    AIDS. 2021;35:701-703.

  377. PETT SL, Spyer M, Haddow LJ, Nhema R, et al
    Benefits of enhanced infection prophylaxis at antiretroviral therapy initiation by cryptococcal antigen status.
    AIDS. 2021;35:585-594.
    PubMed     Abstract available

  378. DALEL J, Ung SK, Hayes P, Black SL, et al
    HIV-1 infection and the lack of viral control are associated with greater expression of interleukin-21 receptor on CD8+ T cells.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96472.
    PubMed     Abstract available

  379. THIMM MA, Eke AC
    Tenofovir, pregnancy and renal function changes in pregnant women living with HIV.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96471.
    PubMed     Abstract available

  380. DEJONG C, Spinelli MA, Okochi H, Gandhi M, et al
    Tenofovir-based PrEP for COVID-19: an untapped opportunity?
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96470.

  381. BULSTRA CA, Reddy CL, Atun R, Barnighausen T, et al
    Impact of the COVID-19-related global recession on the financing of the global HIV response.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96469.

  382. FRENCH AL, Grennan D, Daubert E, Seaberg EC, et al
    Decreases in markers of monocyte/macrophage activation after hepatitis C eradication in HIV/HCV co-infected women.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96468.
    PubMed     Abstract available

  383. NICKOLAS TL, Barasch J, Mugwanya KK, Branch AD, et al
    Kidney injury biomarkers during exposure to tenofovir-based pre-exposure prophylaxis.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96467.
    PubMed     Abstract available

  384. MERCURIO V, Fitzgerald W, Vanpouille C, Molodtsov I, et al
    Mechanisms of residual immune activation in HIV-1 infected human lymphoid tissue ex vivo.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96466.
    PubMed     Abstract available

  385. TAKAHASHI N, Ardeshir A, Holder GE, Cai Y, et al
    Comparison of predictors for terminal disease progression in SIV/SHIV-infected rhesus macaques.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96465.
    PubMed     Abstract available

  386. DAVY-MENDEZ T, Napravnik S, Eron JJ, Cole SR, et al
    Racial, ethnic, and gender disparities in hospitalizations among persons with HIV in the United States and Canada, 2005-2015.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96464.
    PubMed     Abstract available

  387. KAPETANOVIC S, Giganti MJ, Abzug MJ, Lindsey JC, et al
    Plasma biomarker factors associated with neurodevelopmental outcomes in children with perinatal HIV infection and controlled viremia.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96463.
    PubMed     Abstract available

  388. WANG Z, Manion MM, Laidlaw E, Rupert A, et al
    Redistribution of brain glucose metabolism in people with HIV after antiretroviral therapy initiation.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96458.
    PubMed     Abstract available

  389. MOUNZER K, Brunet L, Wyatt CM, Fusco JS, et al
    To dose-adjust or not to dose-adjust: 3TC dose in kidney impairment.
    AIDS. 2021 Mar 10. pii: 00002030-900000000-96461.
    PubMed     Abstract available

  390. TAPIA GR, Glynn TR, Miller C, Manuzak JA, et al
    Syndemics and pre-exposure prophylaxis are independently associated with rectal immune dysregulation in sexual minority men.
    AIDS. 2021 Mar 10. pii: 00002030-900000000-96460.
    PubMed     Abstract available

  391. CONNOLLY S, Carlson JM, Schaefer M, Bere A, et al
    HLA-associated preadaptation in HIV Vif is associated with higher set point viral load and faster CD4 decline in Zambian transmission pairs.
    AIDS. 2021 Mar 10. pii: 00002030-900000000-96459.
    PubMed     Abstract available

  392. MORTON T, Chege W, Swann E, Senn TE, et al
    Advancing long-acting and extended delivery HIV prevention and treatment regimens through behavioral science: NIH workshop directions.
    AIDS. 2021 Mar 10. pii: 00002030-900000000-96457.

  393. VAN DEN HOF M, Jellema PEJ, Haar AMT, Scherpbier HJ, et al
    Normal structural brain development in adolescents treated for perinatally acquired HIV: A longitudinal imaging study.
    AIDS. 2021 Mar 8. pii: 00002030-900000000-96462.
    PubMed     Abstract available

  394. A multilevel intervention to reduce stigma among alcohol consuming men living with HIV receiving antiretroviral therapy: findings from a randomized control trial in India: Erratum.
    AIDS. 2021;35:527.

  395. LUO G, Su L, Hu X, Lin YF, et al
    The role of e-commerce platforms in optimizing the HIV care continuum.
    AIDS. 2021;35:521-522.

  396. VANCE DE, Brew BJ
    HIV neurocognitive impairment and Alzheimer's disease: sniffing out the difference.
    AIDS. 2021;35:511-513.

  397. RIOS A
    Kaposi sarcoma: a fresh look.
    AIDS. 2021;35:515-516.

  398. ALDREDGE A, Roth G, Vaidya A, Paula Duarte A, et al
    Preexposure prophylaxis care continuum among transgender women at a patient-centered preexposure prophylaxis program in Atlanta, Georgia.
    AIDS. 2021;35:524-526.

  399. CATTANEO D, Vinti P, Baldelli S, Fusi M, et al
    Differences in tenofovir trough concentrations between branded and generic formulations in people taking PrEP.
    AIDS. 2021;35:522-524.

    February 2021
  400. DE FRANCESCO D, Sabin CA, Winston A, Mallon PWG, et al
    Agreement between self-reported and objective measures of sleep in people with HIV and lifestyle-similar HIV-negative individuals.
    AIDS. 2021 Feb 23. pii: 00002030-900000000-96476.
    PubMed     Abstract available

  401. MCCLUSKEY SM, Kamelian K, Musinguzi N, Kigozi S, et al
    Pre-treatment integrase inhibitor resistance is uncommon in ART-naive individuals with HIV-1 subtype A1 and D infections in Uganda.
    AIDS. 2021 Feb 23. pii: 00002030-900000000-96475.
    PubMed     Abstract available

  402. GUARALDI G, Calza S, Milic J, Calcagno A, et al
    Dolutegravir is not associated with weight gain in ART experienced geriatric patients living with HIV.
    AIDS. 2021 Feb 23. pii: 00002030-900000000-96474.
    PubMed     Abstract available

  403. LI Y, Etemad B, Dele-Oni R, Sharaf R, et al
    Drug resistance mutations in HIV provirus are associated with defective proviral genomes with hypermutation.
    AIDS. 2021 Feb 22. pii: 00002030-900000000-96478.
    PubMed     Abstract available

  404. JAN AK, Moore JV, Wang RJ, Mcging M, et al
    Markers of inflammation and immune activation are associated with lung function in a multicenter cohort of persons with HIV.
    AIDS. 2021 Feb 22. pii: 00002030-900000000-96477.
    PubMed     Abstract available

  405. FALADE-NWULIA O, Seaberg EC, Snider AE, Rinaldo CR, et al
    Outcomes of acute hepatitis B virus (HBV) in HIV infection with and without HBV-active antiretroviral therapy.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96487.
    PubMed     Abstract available

  406. HAYS AG, Schar M, Barditch-Crovo P, Bagchi S, et al
    A randomized, placebo-controlled, double-blinded clinical trial of colchicine to improve vascular health in people living with HIV.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96486.
    PubMed     Abstract available

  407. HOLT M, Broady TR, Mao L, Chan C, et al
    Increasing pre-exposure prophylaxis use and 'net prevention coverage' in behavioural surveillance of Australian gay and bisexual men, 2014-19.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96485.
    PubMed     Abstract available

  408. KIMMEL SD, Walley AY, Lodi S, Forman LS, et al
    Naloxone receipt and overdose prevention care among people with HIV on chronic opioid therapy.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96484.
    PubMed     Abstract available

  409. HATCHER AM, Brittain K, Phillips TK, Zerbe A, et al
    Longitudinal association between intimate partner violence and viral suppression during pregnancy and postpartum in South African women.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96483.
    PubMed     Abstract available

  410. NELSON M, Winston A, Hill A, Mngqibisa R, et al
    Efficacy, safety and CNS effects after switch from efavirenz/tenofovir/emtricitabine to doravirine/tenofovir/lamivudine in a randomized controlled trial.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96482.
    PubMed     Abstract available

  411. MOODLEY Y, Tomita A, de Oliveira T, Tanser F, et al
    HIV viral load and pregnancy loss: Results from a population-based cohort study in rural KwaZulu-Natal, South Africa.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96481.
    PubMed     Abstract available

  412. SHIAU S, Brummel SS, Kennedy EM, Hermetz K, et al
    Longitudinal changes in epigenetic age in youth with perinatally-acquired HIV and youth who are perinatally HIV-exposed uninfected.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96480.
    PubMed     Abstract available

  413. EKENBERG C, Reekie J, Zucco AG, Murray DD, et al
    The association of HLA alleles with clinical disease progression in HIV-positive cohorts with varied treatment strategies.
    AIDS. 2021 Feb 9. pii: 00002030-900000000-96479.
    PubMed     Abstract available

  414. YANG FN, Bronshteyn M, Flowers SA, Dawson M, et al
    Low CD4 nadir exacerbates the impacts of APOE epsilon4 on functional connectivity and memory in adults with HIV.
    AIDS. 2021 Feb 5. pii: 00002030-900000000-96491.
    PubMed     Abstract available

  415. LUPO J, Germi R, Lancar R, Algarte-Genin M, et al
    Prospective evaluation of blood Epstein Barr virus DNA load and antibody profile in HIV-related non-Hodgkin lymphomas.
    AIDS. 2021 Feb 5. doi: 10.1097/QAD.0000000000002839.
    PubMed     Abstract available

  416. MELLOR MM, Bast AC, Jones NR, Roberts NW, et al
    Risk of adverse COVID-19 outcomes for people living with HIV: a rapid review and meta-analysis.
    AIDS. 2021 Feb 3. pii: 00002030-900000000-96494.
    PubMed     Abstract available

  417. ZOU W, Xing J, Wang F, Chen X, et al
    HIV-1LAI Nef blocks the development of hematopoietic stem/ progenitor cells into T lymphoid cells.
    AIDS. 2021 Feb 3. pii: 00002030-900000000-96493.
    PubMed     Abstract available

  418. ROTHAN C, Yero A, Shi T, Farnos O, et al
    ART-treated HIV-infected adults with coronary artery disease are characterized by a distinctive regulatory T-cell signature.
    AIDS. 2021 Feb 3. pii: 00002030-900000000-96492.
    PubMed     Abstract available

  419. HAMZAH L, Post FA
    Effect of menopause on weight gain, insulin and waist circumference in women with HIV who switch antiretroviral therapy to abacavir/lamivudine/dolutegravir.
    AIDS. 2021;35:349-351.

  420. ROTHERAM-BORUS MJ, Wynn A, Stewart J, Almirol E, et al
    Outcomes of HIV-exposed but uninfected children in South Africa over 5 years.
    AIDS. 2021;35:347-349.

  421. JOSEPH DAVEY DL, de Villiers L, Evens E
    Importance of rigorous implementation science studies to scale-up evidence-based interventions to end the HIV epidemic in the United States.
    AIDS. 2021;35:335-336.

  422. MOYO F, Mazanderani AH, Murray T, Sherman GG, et al
    Achieving maternal viral load suppression for elimination of mother-to-child transmission of HIV in South Africa.
    AIDS. 2021;35:307-316.
    PubMed     Abstract available

  423. SALVATORE PP, de Broucker G, Vojnov L, Moss WJ, et al
    Modeling the cost-effectiveness of point-of-care platforms for infant diagnosis of HIV in sub-Saharan African countries.
    AIDS. 2021;35:287-297.
    PubMed     Abstract available

  424. MCENTIRE CRS, Fong KT, Jia DT, Cooper ER, et al
    Central nervous system disease with JC virus infection in adults with congenital HIV.
    AIDS. 2021;35:235-244.
    PubMed     Abstract available

  425. ANDERSSON E, Ambikan A, Brannstrom J, Aralaguppe SG, et al
    High-throughput sequencing reveals a high prevalence of pretreatment HIV-1 drug resistance in Sweden.
    AIDS. 2021;35:227-234.
    PubMed     Abstract available

  426. CAZZANIGA A, Scrimieri R, Galli M, Maier J, et al
    Unveiling the basis of antiretroviral therapy-induced osteopenia: the effects of Dolutegravir, Darunavir and Atazanavir on osteogenesis.
    AIDS. 2021;35:213-218.
    PubMed     Abstract available

  427. WANG Y, Lin X, Wen Y
    Organizing pneumonia-presenting acute respiratory distress syndrome because of paradoxical tuberculosis-immune reconstitution disease?
    AIDS. 2021;35:351-354.

    January 2021
  428. WANG L, Moqueet N, Simkin A, Knight J, et al
    Mathematical modelling of the influence of serosorting on the population-level HIV transmission impact of pre-exposure prophylaxis.
    AIDS. 2021 Jan 29. pii: 00002030-900000000-96503.
    PubMed     Abstract available

  429. MADEDDU G, De Vito A, Cozzi-Lepri A, Cingolani A, et al
    Time spent with viral load
    AIDS. 2021 Jan 29. pii: 00002030-900000000-96502.
    PubMed     Abstract available

  430. OLIVEIRA NL, Kennedy EH, Tibshirani R, Levine A, et al
    Longitudinal 5-year prediction of cognitive impairment among men with HIV disease.
    AIDS. 2021 Jan 29. pii: 00002030-900000000-96501.
    PubMed     Abstract available

  431. MUCCINI C, Galli L, Poli A, Godino C, et al
    Exercise ECG for coronary artery disease screening in people living with HIV: The cordis STUDY.
    AIDS. 2021 Jan 29. pii: 00002030-900000000-96500.
    PubMed     Abstract available

  432. GEBREBRHAN H, Kambaran C, Sivro A, Adhiambo W, et al
    Rectal microbiota diversity in Kenyan men who have sex with men (MSM) is inversely associated with frequency of receptive anal sex, independent of HIV status.
    AIDS. 2021 Jan 29. pii: 00002030-900000000-96499.
    PubMed     Abstract available

  433. CHAN P, Kerr SJ, Kroon E, Colby D, et al
    Cognitive trajectories after treatment in acute HIV infection.
    AIDS. 2021 Jan 29. pii: 00002030-900000000-96498.
    PubMed     Abstract available

  434. NYAKATO P, Schomaker M, Sipambo N, Technau KG, et al
    Virologic response of adolescents living with perinatally acquired HIV receiving antiretroviral therapy in the period of early adolescence (10-14 years) in South Africa.
    AIDS. 2021 Jan 21. pii: 00002030-900000000-96504.
    PubMed     Abstract available

  435. ARANTES I, Bello G, Darcissac E, Lacoste V, et al
    Using phylogenetic surveillance and epidemiological data to understand the HIV-1 transmission dynamics in French Guiana.
    AIDS. 2021 Jan 18. pii: 00002030-900000000-96506.
    PubMed     Abstract available

  436. JOHNSTON PI, Wright SW, Orr M, Pearce FA, et al
    Worldwide relative smoking prevalence among people living with and without HIV: a systematic review and meta-analysis.
    AIDS. 2021 Jan 18. pii: 00002030-900000000-96505.
    PubMed     Abstract available

    Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents.
    AIDS. 2021 Jan 13. pii: 00002030-900000000-96508.
    PubMed     Abstract available

  438. KANG R, Li J, Chen H, Tang Z, et al
    Using longitudinal genetic-network study to understand HIV treatment-as-prevention: a population-based observational study.
    AIDS. 2021 Jan 13. pii: 00002030-900000000-96507.
    PubMed     Abstract available

  439. LIU FF, Hall V, Cronin KM, Nair AP, et al
    'Peeling back the onion layers': the challenge of HIV-associated multicentric Castleman's disease.
    AIDS. 2021;35:159-161.

  440. ASHOK A, Hoy J, Spelman D, McMahon J, et al
    Successful treatment of disseminated Mycobacterium simiae infection in a patient with advanced HIV.
    AIDS. 2021;35:157-158.

  441. TRAEGER MW, Patel P, Guy R, Hellard ME, et al
    Changes in HIV preexposure prophylaxis prescribing in Australian clinical services following COVID-19 restrictions.
    AIDS. 2021;35:155-157.

  442. ZIEGLER MC, Naidoo K, Chapel A, Nkotwana S, et al
    HIV-1 evades a Gag mutation that abrogates killer cell immunoglobulin-like receptor binding and disinhibits natural killer cells in infected individuals with KIR2DL2+/HLA-C*03: 04+ genotype.
    AIDS. 2021;35:151-154.
    PubMed     Abstract available

  443. RAMASWAMI R, Lurain K, Marshall VA, Rupert A, et al
    Elevated IL-13 in effusions of patients with HIV and primary effusion lymphoma as compared with other Kaposi sarcoma herpesvirus-associated disorders.
    AIDS. 2021;35:53-62.
    PubMed     Abstract available

    December 2020
  444. LAM JO, Hou CE, Hojilla JC, Anderson AN, et al
    Comparison of dementia risk after age 50 between individuals with and without HIV infection.
    AIDS. 2020;Publish Ahead of Print.
    PubMed     Abstract available

  445. BRANDAO M, Bruzzone M, Franzoi MA, de Angelis C, et al
    Impact of HIV infection on baseline characteristics and survival of women with breast cancer: a systematic review and meta-analysis.
    AIDS. 2020;Publish Ahead of Print.
    PubMed     Abstract available

  446. RITTENHOUSE KJ, Mwape H, Nelson JA, Mwale J, et al
    Maternal HIV, antiretroviral timing, and spontaneous preterm birth in an urban Zambian cohort: the role of local and systemic inflammation.
    AIDS. 2020;Publish Ahead of Print.
    PubMed     Abstract available

  447. NTHOBATSANG K, Ncenga TL, Mwangi-Woto C, Wedu TJ, et al
    Lack of RH2 gene expression may have influenced the HIV pandemic in sub-Saharan Africa.
    AIDS. 2020;Publish Ahead of Print.
    PubMed     Abstract available

  448. BUDD A, Krentz HB, Rubin LH, Power C, et al
    Long-term consequences of interpersonal violence experiences on treatment engagement and health status in people living with HIV.
    AIDS. 2020;Publish Ahead of Print.
    PubMed     Abstract available

  449. NGONGO NM, Nani-Tuma HS, Mambimbi MM, Mashi ML, et al
    Progressive phasing out of baseline CD4 cell count testing for people living with HIV in Kinshasa, DRC.
    AIDS. 2020;Publish Ahead of Print.

  450. TORDOFF DM, Buskin S, Lechtenberg R, Golden MR, et al
    Combining traditional and molecular epidemiology methods to quantify local HIV transmission among foreign-born residents of King County, Washington.
    AIDS. 2020 Dec 10. doi: 10.1097/QAD.0000000000002783.
    PubMed     Abstract available

  451. KIMURA CMS, Nahas CSR, Silva-Filho EV, Ribeiro VL, et al
    High-risk HPV test in anal smears: can it optimize the screening for anal cancer?
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002795.
    PubMed     Abstract available

  452. HICKEY MD, Imbert E, Glidden DV, Rosario JBD, et al
    Viral suppression not decreased during COVID-19 among people with HIV and unstable housing enrolled in a low-barrier clinic-based program (POP-UP).
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002793.
    PubMed     Abstract available

  453. MOCROFT A
    The relationship between smoking, current CD4, viral load and cancer in persons living with HIV.
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002791.
    PubMed     Abstract available

  454. FALASCA K, Lanuti P, Ucciferri C, Pieragostino D, et al
    Circulating extracellular vesicles as new inflammation marker in hiv infection.
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002794.
    PubMed     Abstract available

  455. HANDOKO R, Chan P, Jagodzinski L, Pinyakorn S, et al
    Minimal detection of cerebrospinal fluid escape after initiation of antiretroviral therapy in acute HIV-1 infection.
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002786.
    PubMed     Abstract available

  456. MU W, Sharma M, Heymans R, Ritou E, et al
    ApoA-I mimetics attenuate macrophage activation in chronic treated HIV.
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002785.
    PubMed     Abstract available

  457. XIANG Y, Fujimoto K, Li F, Wang Q, et al
    Identifying influential neighbors in social networks and venue affiliations among young MSM: A data science approach to predict HIV infection.
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002784.
    PubMed     Abstract available

  458. FIORENTINO M, Eubanks A, Coulaud PJ, Couderc C, et al
    Homonegativity, sexual violence and condom use with women in men who have sex with men and women in West Africa (CohMSM).
    AIDS. 2020 Dec 9. doi: 10.1097/QAD.0000000000002782.
    PubMed     Abstract available

  459. ESTCOURT C, Yeung A, Nandwani R, Goldberg D, et al
    Population-level effectiveness of a national HIV preexposure prophylaxis programme in MSM.
    AIDS. 2020 Dec 7. doi: 10.1097/QAD.0000000000002790.
    PubMed     Abstract available

  460. BAILEY JV, Wayal S, Aicken CRH, Webster R, et al
    Interactive digital interventions for prevention of sexually transmitted HIV: systematic review and meta-analyses.
    AIDS. 2020 Dec 4. doi: 10.1097/QAD.0000000000002780.
    PubMed     Abstract available

  461. ONG JJ, Chow EPF, Read D, Taj U, et al
    Nudgeathons to control HIV: designing strategies using behavioural economics.
    AIDS. 2020;34:2337-2340.

  462. AVDOSHINA V, Mocchetti I
    HIV-associated neurodegenerative disorders: extracellular and intracellular mechanisms.
    AIDS. 2020;34:2334-2336.

  463. ZHAO T
    HIV-associated neurodegenerative disorders: role of endoplasmic reticulum in Gp120-mediated neurotoxicity.
    AIDS. 2020;34:2333-2334.

  464. VINIKOOR MJ, Hachaambwa L
    Advanced HIV disease during the 'Treat All' era in Botswana.
    AIDS. 2020;34:2321-2323.

  465. ZIMMERMANN HML, Jongen VW, Boyd A, Hoornenborg E, et al
    Decision-making regarding condom use among daily and event-driven users of preexposure prophylaxis in the Netherlands.
    AIDS. 2020;34:2295-2304.
    PubMed     Abstract available

  466. MONACO DC, Zapata L, Hunter E, Salomon H, et al
    Resistance profile of HIV-1 quasispecies in patients under treatment failure using single molecule, real-time sequencing.
    AIDS. 2020;34:2201-2210.
    PubMed     Abstract available

  467. ABRAHAMS N, Mhlongo S, Dunkle K, Chirwa E, et al
    Increase in HIV incidence in women exposed to rape: a comparative cohort study.
    AIDS. 2020 Dec 1. doi: 10.1097/QAD.0000000000002779.
    PubMed     Abstract available

  468. WOOD BR
    Tenofovir alafenamide versus tenofovir disoproxil fumarate: integrating systematic review findings into practice and policy.
    AIDS. 2020;34:2319-2320.

    November 2020
  469. MARTY L, Lemsalu L, Kivite-Urtane A, Costagliola D, et al
    Revealing HIV epidemic dynamics and contrasting responses in two WHO Eastern European countries: insights from modeling and data triangulation.
    AIDS. 2020 Nov 30. doi: 10.1097/QAD.0000000000002778.
    PubMed     Abstract available

  470. SEYEDALINAGHI S, Taj L, Mazaheri-Tehrani E, Ahsani-Nasab S, et al
    HIV in Iran: onset, responses and future directions.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002757.
    PubMed     Abstract available

  471. XIA Y, Milwid RM, Godin A, Boily MC, et al
    Accuracy of self-reported HIV testing history and awareness of HIV-positive status among people living with HIV in four Sub-Saharan African countries.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002759.
    PubMed     Abstract available

  472. SUNDERMANN EE, Fields A, Saloner R, Gouaux B, et al
    The utility of olfactory function in distinguishing early stage Alzheimer's disease from HIV-associated neurocognitive disorder.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002761.
    PubMed     Abstract available

  473. MCFALL AM, Lau B, Latkin C, Srikrishnan AK, et al
    Optimizing respondent driven sampling to find undiagnosed HIV-infected people who inject drugs.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002763.
    PubMed     Abstract available

  474. ROSEBUSH JC, Best BM, Chadwick EG, Butler K, et al
    Pharmacokinetics and safety of maraviroc in neonates.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002762.
    PubMed     Abstract available

  475. TREVILLYAN JM, Dart A, Paul E, Cavassini M, et al
    Impact of rosuvastatin on atherosclerosis in people with HIV at moderate cardiovascular risk; a randomised, controlled trial.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002764.
    PubMed     Abstract available

  476. DESMONDE S, Ciaranello AL, Malateste K, Musick B, et al
    Age-specific mortality rate ratios in adolescents and youth aged 10-24 years living with perinatally versus non-perinatally-acquired HIV.
    AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002765.
    PubMed     Abstract available

  477. HUAMAN MA, Juchnowski SM, Zidar DA, Kityo CM, et al
    Monocyte activation in persons living with HIV and tuberculosis coinfection.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002766.
    PubMed     Abstract available

  478. BROOKS KM, Momper JD, Pinilla M, Stek AM, et al
    Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV: Results from IMPAACT P1026s.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002767.
    PubMed     Abstract available

  479. COOLEY SA, Paul RH, Strain JF, Boerwinkle A, et al
    Effects of anticholinergic medication use on brain integrity in persons living with HIV and persons without HIV.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002768.
    PubMed     Abstract available

  480. BOETTIGER DC, Kerr S, Chattranukulchai P, Siwamogsatham S, et al
    Maintenance of statin therapy among people living with HIV.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002769.
    PubMed     Abstract available

  481. GROENE EA, Valeris-Chacin RJ, Stadelman AM, Safo SE, et al
    Maternal HIV and child anthropometric outcomes over time: An analysis of Zimbabwe demographic health surveys from 2005-2015.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002772.
    PubMed     Abstract available

  482. BAKER JV, Wolfson J, Collins G, Morse C, et al
    Losartan to reduce inflammation and fibrosis endpoints in HIV disease (LIFE-HIV): results from a randomized placebo-controlled trial.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002773.
    PubMed     Abstract available

  483. ZEZIULIN O, Mollan KR, Shook-Sa BE, Hanscom B, et al
    Depressive symptoms and use of HIV care and medication-assisted treatment among people living with HIV who inject drugs.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002774.
    PubMed     Abstract available

  484. TSHIKUNG ON, Smit M, Marinosci A, Buvelot H, et al
    Caring for people living with HIV during the global COVID-19 pandemic.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002775.

  485. GARCIA M, Morcilla V, Navarrete-Munoz MA, Fisher K, et al
    HIV-DNA Content in pTfh Cells is Associated with Residual Viremia in Elite Controllers.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002776.
    PubMed     Abstract available

  486. VELLOZA J, Kapogiannis B, Bekker LG, Celum C, et al
    Interventions to improve daily medication use among adolescents and young adults: what can we learn for youth PrEP services?
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002777.
    PubMed     Abstract available

  487. ERLANDSON KM, Wu K, Lake JE, Samuels DC, et al
    Mitochondrial DNA haplogroups and weight gain following switch to INSTI-Based ART.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002771.
    PubMed     Abstract available

  488. HUGHES K, Chang J, Stadtler H, Wyatt C, et al
    HIV-1 infection of the kidney: mechanisms and implications.
    AIDS. 2020 Nov 20. doi: 10.1097/QAD.0000000000002753.
    PubMed     Abstract available

  489. CHOW FC, Ma Y, Manion M, Rupert A, et al
    Factors associated with worse cerebrovascular function in aging women with and at risk for HIV.
    AIDS. 2020 Nov 20. doi: 10.1097/QAD.0000000000002755.
    PubMed     Abstract available

  490. Recently acquired and early chronic hepatitis C in MSM: Recommendations from the European treatment network for HIV, hepatitis and global infectious diseases Consensus panel: Erratum.
    AIDS. 2020;34:2161-2163.

  491. HIV-associated plasmablastic lymphoma in the era of HAART: a single-center experience of 21 patients: Erratum.
    AIDS. 2020;34:2159.

  492. MUCCINI C, Spagnuolo V, Canetti D, Bigoloni A, et al
    Cerebrospinal fluid viral replication and burden of resistance in three HIV-1-infected people taking Ibalizumab with multiple drug class-wide resistance.
    AIDS. 2020;34:2152-2155.

  493. SOUDEYNS H, Dumond J
    Unexpectedly low levels of transplacental transfer of second-generation integrase strand transfer inhibitors bictegravir and cabotegravir.
    AIDS. 2020;34:2137-2139.

  494. LEVY JA, Coutinho RA, Saag MS
    AIDS new editor announcement.
    AIDS. 2020;34:1995.

  495. FARR ZUEND C, Noel-Romas L, Hoger S, Mccorriser S, et al
    Influence of dapivirine vaginal ring use on cervicovaginal immunity and functional microbiome in adolescent girls.
    AIDS. 2020 Nov 11. doi: 10.1097/QAD.0000000000002751.
    PubMed     Abstract available

  496. BEDIMO RJ, Park LS, Shebl F, Sigel K, et al
    Statin exposure and risk of cancer in people with and without HIV infection.
    AIDS. 2020 Nov 11. doi: 10.1097/QAD.0000000000002748.
    PubMed     Abstract available

  497. SEVERIN D, Faiza B, Nadia M, Aurelie DT, et al
    Kaposi sarcoma in people living with HIV: a comparative study of classic and HIV-viremic and aviremic AIDS Kaposi Sarcoma.
    AIDS. 2020 Nov 11. doi: 10.1097/QAD.0000000000002744.
    PubMed     Abstract available

  498. ADAMS JW, Khan MR, Bessey SE, Friedman SR, et al
    Pre-exposure prophylaxis (PrEP) strategies for African American Women Affected by Mass Incarceration: A Modeling Study.
    AIDS. 2020 Nov 9. doi: 10.1097/QAD.0000000000002749.
    PubMed     Abstract available

  499. REIN SM, Lampe FC, Johnson MA, Bhagani S, et al
    All-cause hospitalisation according to demographic group in people living with HIV in the current ART era: Recent findings from a cohort study in the UK.
    AIDS. 2020 Nov 9. doi: 10.1097/QAD.0000000000002750.
    PubMed     Abstract available

  500. NICHOLS BE, Cele R, Jamieson L, Long LC, et al
    Community-based delivery of HIV treatment in Zambia: costs and outcomes.
    AIDS. 2020 Nov 5. doi: 10.1097/QAD.0000000000002737.
    PubMed     Abstract available

  501. COLLINS LF, Colasanti JA, Nguyen ML, Moran CA, et al
    The COVID-19 pandemic as a catalyst for differentiated care models to end the HIV epidemic in the U.S. - applying lessons from high-burden settings.
    AIDS. 2020 Nov 5. doi: 10.1097/QAD.0000000000002746.

  502. PASVOL TJ, Teh J, Balfoussia D, Hall R, et al
    Outcomes of fertility investigations in a cohort of adults with perinatally acquired HIV-1 infection: a UK cross-sectional observational study.
    AIDS. 2020 Nov 5. doi: 10.1097/QAD.0000000000002745.
    PubMed     Abstract available

  503. TAGO A, McKinnon LR, Wanjiru T, Muriuki F, et al
    Declines in HIV prevalence in female sex workers (FSWs) accessing an HIV treatment and prevention programme in Nairobi, Kenya over a 10-year period.
    AIDS. 2020 Nov 5. doi: 10.1097/QAD.0000000000002747.
    PubMed     Abstract available

  504. Assessing the validity of and factors that influence accurate self-reporting of HIV status after testing: a population-based study: Erratum.
    AIDS. 2020;34:1993.

  505. GREEN M
    A letter to a young HIV doctor.
    AIDS. 2020;34:1991-1992.

  506. GABUZDA D, McArthur JC, Letendre SL
    Efficacy and safety of two-drug regimens for treatment of HIV in the central nervous system.
    AIDS. 2020;34:1975-1977.

  507. PYRA M, Rusie L, Castro M, Keglovitz Baker K, et al
    A taxonomy of pragmatic measures of HIV preexposure prophylaxis use.
    AIDS. 2020;34:1951-1957.
    PubMed     Abstract available

  508. MILIC J, Menozzi V, Schepis F, Malagoli A, et al
    Liver steatosis and nonalcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV.
    AIDS. 2020;34:1915-1921.
    PubMed     Abstract available

  509. LO B
    Toward respectful research with Indigenous people.
    AIDS. 2020;34:1979-1981.

  510. ROELOFSEN EE, Wildenbeest S, Mollema FP, Burger DM, et al
    Pharmacokinetics of tenofovir disoproxyl fumarate/emtricitabine in a client on pre-exposure prophylaxis after a total gastrectomy.
    AIDS. 2020;34:1989-1991.

    October 2020
  511. SUGAWARA S, Manickam C, Reeves RK
    TRIGGERED: could refocused cell signaling be key to NK cell-based HIV immunotherapeutics?
    AIDS. 2020 Oct 27. doi: 10.1097/QAD.0000000000002743.
    PubMed     Abstract available

  512. SHERMAN BT, Hu X, Singh K, Haine L, et al
    Genome-wide association study of high-sensitivity C-reactive protein, D-dimer and Interleukin-6 levels in multi-ethnic HIV+ cohorts.
    AIDS. 2020 Oct 20. doi: 10.1097/QAD.0000000000002738.
    PubMed     Abstract available

  513. CHANDIWANA NC, Chersich M, Venter WF, Akpomiemie G, et al
    Unexpected interactions between dolutegravir and folate: randomised trial evidence from South Africa.
    AIDS. 2020 Oct 20. doi: 10.1097/QAD.0000000000002741.
    PubMed     Abstract available

  514. CHLOE O, Elion R, Thompson M, Rockstroh JK, et al
    Changes in weight and body mass index with first-line doravirine-based therapy: a pooled analysis of three randomized controlled trials.
    AIDS. 2020 Oct 13. doi: 10.1097/QAD.0000000000002725.
    PubMed     Abstract available

  515. PINTYE J, Huo Y, Kacanek D, Zhang K, et al
    Detectable HIV RNA in late pregnancy associated with low tenofovir hair levels at time of delivery among women living with HIV in the United States.
    AIDS. 2020 Oct 12. doi: 10.1097/QAD.0000000000002730.
    PubMed     Abstract available

  516. TEMU TM, Zifodya JS, Polyak SJ, Wagoner J, et al
    Antiretroviral therapy reduces but does not normalize immune and vascular inflammatory markers in adults with chronic HIV infection in Kenya.
    AIDS. 2020 Oct 12. doi: 10.1097/QAD.0000000000002729.
    PubMed     Abstract available

  517. BAJEMA KL, Nance RM, Delaney JAC, Eaton E, et al
    Significant decline in heavily treatment experienced persons with HIV with limited antiretroviral treatment options in the US, 2000-2017.
    AIDS. 2020 Oct 12. doi: 10.1097/QAD.0000000000002679.
    PubMed     Abstract available

  518. WHITEMAN A, Baugher A, Sionean C
    Assessing self-reported discrimination among men who have sex with men.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002711.
    PubMed     Abstract available

  519. LU D, Sun H, Yu J, Kuang YQ, et al
    Chemsex drugs regulate HIV infection and replication in immune cells: A vicious circle.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002708.

  520. KOHLI M, Moore DJ, Moore RC
    Using health technology to capture digital phenotyping data in HIV-associated neurocognitive disorders.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002726.

  521. GILMORE JC, Serghides L, Bendayan R
    Differential effects of antiretroviral drug toxicity in male versus female children who are HIV-exposed but uninfected.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002707.
    PubMed     Abstract available

  522. DES JARLAIS DC, Duong Thi H, Khuat Thi Hai O, Feelemyer JP, et al
    Ending an HIV epidemic among persons who inject drugs (PWID) in a middle-income country: extremely low HIV incidence among PWID in Hai Phong, Viet Nam.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002712.
    PubMed     Abstract available

  523. ROURKE SB, Bekele T, Rachlis A, Kovacs C, et al
    Asymptomatic neurocognitive impairment is a risk for symptomatic decline in a large HIV Canadian cohort study.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002709.
    PubMed     Abstract available

  524. AUDET CM, Ngobeni S, Mkansi M, Wafawanaka F, et al
    An unrecognized key population? traditional treatment practices associated with HIV risk among traditional healers in rural South Africa.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002710.
    PubMed     Abstract available

  525. SHANGANI S, Bhaskar N, Richmond N, Operario D, et al
    A systematic review of early adoption of implementation science for HIV prevention or treatment in the United States.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002713.
    PubMed     Abstract available

  526. ZIMMERMANN HML, Jongen VW, Boyd A, Hoornenborg E, et al
    Decision-making regarding condom use among daily and event-driven users of pre-exposure prophylaxis in the Netherlands - a mixed-methods analysis.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002714.
    PubMed     Abstract available

  527. SIBIUDE J, Le Chenadec J, Mandelbrot L, Dollfus C, et al
    Risk of birth defects and perinatal outcomes in HIV-infected women exposed to integrase strand inhibitors during pregnancy.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002719.
    PubMed     Abstract available

  528. NJUGUNA IN, Wagner AD, Neary J, Omondi VO, et al
    Financial incentives to increase pediatric hiv testing: a randomized trial.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002720.
    PubMed     Abstract available

  529. CARLANDER C, Wagner P, Yilmaz A, Sparen P, et al
    Employment by HIV status, mode of HIV transmission and migrant status: a nation-wide population-based study with twenty years of follow-up.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002724.
    PubMed     Abstract available

  530. SHANAUBE K, Schaap A, Hoddinott G, Mubekapi-Musadaidzwa C, et al
    Impact of a community-wide combination HIV prevention intervention on knowledge of HIV status among adolescents.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002722.
    PubMed     Abstract available

  531. HSU R, Brunet L, Fusco JS, Mounzer K, et al
    Incident Type 2 diabetes mellitus after initiation of common HIV antiretroviral drugs.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002718.
    PubMed     Abstract available

  532. JONES CI, Rose SL, Shutt A, Cairo C, et al
    Maternal HIV status skews transcriptomic response in infant cord blood monocytes exposed to BCG.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002706.
    PubMed     Abstract available

  533. ZHANG J, Thakuri BKC, Zhao J, Nguyen LN, et al
    LncRNA HOTAIRM1 promotes MDSC expansion and suppressive functions through up-regulating HOXA1 expression during latent HIV infection.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002700.
    PubMed     Abstract available

  534. HESSOL NA, Barrett BW, Margolick JB, Plankey M, et al
    Risk of smoking-related cancers among women and men living with and without hiv.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002717.
    PubMed     Abstract available

  535. WAGMAN JA, Wynn A, Matsuzaki M, Gnatienko N, et al
    Hazardous alcohol use, antiretroviral therapy receipt and viral suppression in people living with HIV who inject drugs in the U.S., India, Russia and Vietnam.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002716.
    PubMed     Abstract available

  536. VONASEK B, Kay A, Devezin T, Bacha JM, et al
    Tuberculosis symptom screening for children and adolescents living with HIV in six high HIV/TB burden countries in Africa.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002715.
    PubMed     Abstract available

  537. ZIEGLER MC, Naidoo K, Chapel A, Nkotwana S, et al
    HIV-1 evades a gag mutation that abrogates KIR binding and disinhibits NK cells in infected individuals with KIR2DL2+/HLA-C*03: 04+ genotype.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002721.
    PubMed     Abstract available

  538. PILKINGTON V, Hughes SL, Pepperrell T, McCann K, et al
    Tenofovir alafenamide versus tenofovir disoproxil fumarate - an updated meta-analysis of 14,894 patients across 14 trials.
    AIDS. 2020 Oct 8. doi: 10.1097/QAD.0000000000002699.
    PubMed     Abstract available

  539. MURAKOSHI H, Chikata T, Akahoshi T, Zou C, et al
    Critical effect of Pol escape mutations associated with detrimental allele HLA-C*15: 05 on clinical outcome in HIV-1 subtype A/E infection.
    AIDS. 2020 Oct 6. doi: 10.1097/QAD.0000000000002704.
    PubMed     Abstract available

  540. SERRANO PA, Daubert E, Munoz A, Hosek SG, et al
    Effect of Truvada lawsuit advertising on PrEP attitudes and decisions among sexual and gender minority youth and young adults at risk for HIV.
    AIDS. 2020 Oct 6. doi: 10.1097/QAD.0000000000002728.
    PubMed     Abstract available

  541. GRANT M
    Regulation of natural killer cells: analog peptide handshake goes digital.
    AIDS. 2020;34:1857-1858.

  542. EL-SADR WM
    What one pandemic can teach us in facing another.
    AIDS. 2020;34:1757-1759.

    September 2020
  543. MONACO DC, Zapata L, Hunter E, Salomon H, et al
    Resistance Profile of Human Immunodeficiency Virus 1 (HIV-1) Quasispecies in Patients Under Treatment Failure Using Single Molecule, Real-Time (SMRT) Sequencing.
    AIDS. 2020 Sep 25. doi: 10.1097/QAD.0000000000002697.
    PubMed     Abstract available

  544. LEVY JA
    The need to reassess our approaches at HIV cure and prevention.
    AIDS. 2020 Sep 25. doi: 10.1097/QAD.0000000000002695.

  545. RAMASWAMI R, Lurain K, Marshall VA, Rupert A, et al
    Elevated IL-13 in effusions of patients with HIV and primary effusion lymphoma as compared with other KSHV-associated disorders.
    AIDS. 2020 Sep 17. doi: 10.1097/QAD.0000000000002692.
    PubMed     Abstract available

  546. CHIAO E, Lensing SY, Wiley DJ, Deshmukh AA, et al
    Screening strategies for the detection of anal high-grade squamous intraepithelial lesions in women living with HIV.
    AIDS. 2020 Sep 17. doi: 10.1097/QAD.0000000000002694.
    PubMed     Abstract available

  547. YOTSUMOTO M, Hachiya A, Ichiki A, Amano K, et al
    Second-generation integrase strand inhibitors can be effective against elvitegravir-derived multiple integrase gene substitutions.
    AIDS. 2020 Sep 14. doi: 10.1097/QAD.0000000000002688.

  548. BANDA FM, Powis KM, Sun S, Makhema J, et al
    Fetal biometry following in utero exposure to dolutegravir- or efavirenz-based antiretroviral therapy.
    AIDS. 2020 Sep 8. doi: 10.1097/QAD.0000000000002674.

  549. SEELEY J, Blanc AK
    Reducing stigma and discrimination: new evidence and its implications.
    AIDS. 2020;34 Suppl 1:S1-S4.

    June 2020
  550. YADAVA SK, Vyas V, Jain H, Fazili T, et al
    Thrombotic thrombocytopenic purpura associated with AIDS: challenges in diagnosis and management.
    AIDS. 2020;34:1101-1102.

  551. ASHIGBIE PG, Laing RO, Wirtz VJ, Nkrumah N, et al
    Registration timelines of antiretroviral medicines in Ghana and Kenya.
    AIDS. 2020;34:1093-1095.
    PubMed     Abstract available

    March 2020
  552. ALAEI K, Zaidi H
    A centralized or decentralized approach when it comes to socially stigmatized health concerns in conservative social settings.
    AIDS. 2020;34:647-649.

  553. JAMES CW, Szabo S, Kahal D, Goldstein ND, et al
    The effect of multivitamins and polyvalent cations on virologic suppression with integrase strand transfer inhibitors.
    AIDS. 2020;34:487-489.

    In-vivo use of SIVmac239 with a reversing stop codon in the SIV nef gene.
    AIDS. 2020;34:487.

    February 2020
  555. LIN KS, Win S, Nyein PP
    Drug-induced immune hemolytic anemia because of efavirenz: a case report.
    AIDS. 2020;34:326-328.

    December 2019
  556. CARR M, Richardson R, Tong W, Bloch M, et al
    Switch from tenofovir DF to raltegravir is not associated with weight gain over 96 weeks.
    AIDS. 2019 Dec 27. doi: 10.1097/QAD.0000000000002473.
    PubMed     Abstract available

    September 2019
  557. LAPADULA G, Bernasconi DP, Bai F, Foca E, et al
    Switching from efavirenz to rilpivirine improves sleep quality and self-perceived cognition but has no impact on neurocognitive performances: Results from a randomized controlled trial.
    AIDS. 2019 Sep 26. doi: 10.1097/QAD.0000000000002377.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.